Molecule ChEMBL ID,Molecule Name,Molecule Max Phase,Molecular Weight,#RO5 Violations,AlogP,Compound Key,smiles,Standard Type,Standard Relation,Standard Value,Standard Units,pChEMBL Value,Data Validity Comment,Comment,Uo Units,Ligand Efficiency BEI,Ligand Efficiency LE,Ligand Efficiency LLE,Ligand Efficiency SEI,Potential Duplicate,Assay ChEMBL ID,Assay Description,Assay Type,BAO Format ID,BAO Label,Assay Organism,Assay Tissue ChEMBL ID,Assay Tissue Name,Assay Cell Type,Assay Subcellular Fraction,Assay Parameters,Assay Variant Accession,Assay Variant Mutation,Target ChEMBL ID,Target Name,Target Organism,Target Type,Document ChEMBL ID,Source ID,Source Description,Document Journal,Document Year,Cell ChEMBL ID,Properties,Action Type,Standard Text Value,Value
CHEMBL2104148,CLOCOUMAROL,2.0,356.85,1.0,5.21,"1, clocoumarol",CCCC(c1ccc(CCCl)cc1)c1c(O)c2ccccc2oc1=O,Drug metabolism,'>',90.0,%,,,,UO_0000187,,,,,0,CHEMBL3253854,"Drug metabolism in Wistar albino rat liver microsomes assessed as formation of 6-[1-Hydroxy-2-oxo-3-[p-(2-chloroethyl)phenyl]hexylidene]-2,4-cyclohexadien-1-one at 5 umol after 30 mins TLC analysis in presence of NADPH generating system",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,90.0
CHEMBL3357339,,,400.91,0.0,2.76,6,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n([C@H](C)CO)c2n1,Drug metabolism,'=',50.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,50.0
CHEMBL3139150,,,427.94,0.0,2.34,10,CC(=O)NCCn1c(-c2ccccc2Cl)nc2c(N3CCN(C)CC3)nc(C)nc21,Drug metabolism,'=',0.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,0.0
CHEMBL3099820,,,504.85,2.0,5.73,3d,CC(C)(C)n1nnnc1C(NCCNc1ccnc2cc(Cl)ccc12)c1ccc(Cl)c(Cl)c1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3100378,Drug metabolism in rat liver microsomes assessed as 2-(5-((4-chlorophenyl)(2-(7-chloroquinolin-4-ylamino)ethylamino)methyl)-1H-tetrazol-1-yl)-2-methylpropan-1-ol level at 5 uM after 1 hr by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3098028,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,
CHEMBL3823351,,,366.45,0.0,2.86,(+)-24,C[C@@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccc(CCO)cn2)n1,Drug metabolism,'=',47.4,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,47.4
CHEMBL1783834,GINSENOSIDE RH2,,622.88,2.0,4.32,Rh2,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3540856,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as epoxide metabolites at 10 uM for 60 mins by NAC/conjugate assay,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL555017,GAMBOGIC ACID,,628.76,2.0,7.24,"GA, M0",CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3535491,Drug metabolism in rat liver microsomes assessed as glucuronidation product formation at 50 uM preincubated for 10 mins followed by UDPGA addition for 2 hrs measured 2 hrs post NaOH treatment by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3740772,,,294.31,0.0,2.81,3,CC(=O)Nc1ccc2c(c1)C(=O)c1cc(NC(C)=O)ccc1-2,Drug metabolism,,,,,,tde,,,,,,0,CHEMBL3742761,Drug metabolism in rat liver microsomes assessed as [M+ H-16] formation by LC/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3739289,1,Scientific Literature,Medchemcomm,2015,,,,,
CHEMBL3753703,,,387.57,0.0,3.4,2e,CC(C)CN1CCC(NC(=O)c2ccc(OC3CCN(C(C)C)CC3)cc2)C1,Drug metabolism,'=',8.0,%,,,,UO_0000187,,,,,0,CHEMBL3755250,Metabolic stability in rat liver microsomes assessed as compound metabolized after 30 mins by LC-MS/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3751729,1,Scientific Literature,Eur J Med Chem,2016,,,,,8.0
CHEMBL3526472,,,443.46,0.0,3.42,[14C]-Brivanib alaninate,Cc1cc2c(F)c(Oc3n[14cH]nn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3534816,"Drug metabolism in rat liver microsomes assessed as 1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-one formation at 2 uM after 60 mins by LC/MS method in absence of NADPH",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3401173,,,241.25,0.0,1.6,3a,O=c1[nH]ccc2nc(COc3ccccc3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401187,,,353.33,0.0,3.34,3o,O=c1n(-c2ccc(F)cc2)ccc2nc(COc3cccc(F)c3)cn12,Drug metabolism,'=',28.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,28.0
CHEMBL3401189,,,349.37,0.0,3.51,3q,Cc1cccc(OCc2cn3c(=O)n(-c4ccc(F)cc4)ccc3n2)c1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401191,,,336.33,0.0,2.6,3s,O=c1n(-c2ccc(F)cc2)ccc2nc(COc3cccnc3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3104887,,,509.97,1.0,4.96,5,O=C1c2cc(C3CC3)nc(Oc3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)c2C(=O)N1C1CC1,Drug metabolism,'=',37.0,%,,,,UO_0000187,,,,,0,CHEMBL3106555,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3102800,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,37.0
CHEMBL165676,,,464.48,0.0,3.88,15,COc1ccc([C@H]2Cc3c(cccc3C(F)(F)F)N(CCN(C)C)C(=O)[C@H]2OC(C)=O)cc1,Drug metabolism,'=',31.0,%,,,,UO_0000187,,,,,0,CHEMBL3134874,Drug metabolism in rat liver microsomes assessed as N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3132812,1,Scientific Literature,Medchemcomm,2013,,,,,31.0
CHEMBL3114000,,,484.42,0.0,2.49,23,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cn1,Drug metabolism,,,,,,Not Active,,,,,,0,CHEMBL3119597,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112561,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3358436,,,359.43,0.0,2.81,"12, AM-0822",CCn1nccc1Oc1cc(CC2CCOCC2)cnc1NC(=O)NC,Drug metabolism,'=',25.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,25.0
CHEMBL3792751,,,375.83,0.0,3.64,5y,Fc1ccc2c(CN3CCO[C@H](COc4cccc(Cl)n4)C3)c[nH]c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3796320,Drug metabolism in rat liver microsomes assessed as oxidative dealkylated metabolite formation in presence of NADPH,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3792377,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,
CHEMBL2180905,,,548.58,1.0,3.71,1,CS(=O)(=O)c1ccc(F)cc1C(=O)N1CCC(N(C2CC2)S(=O)(=O)c2cccc(C(F)(F)F)c2)CC1,Drug metabolism,'=',0.01,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.01
CHEMBL3787668,,,447.58,0.0,4.29,B,Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3792013,"Drug metabolism in rat liver microsomes assessed as 3-(4-amino-7-((cis)-3-(azetidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenol metabolite formation after 1 hr by capillary-HPLC/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3785066,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,
CHEMBL762,OXYMETAZOLINE,4.0,260.38,0.0,2.85,Oxymetazoline,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535099,"Drug metabolism in NADPH supplemented rat liver microsomes fraction assessed as 3-((1H-imidazol-2-yl)methyl)-6-tert-butyl-2,4-dimethylphenol formation at 50 uM after 1 hr by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525902,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL33899,,,354.45,1.0,6.15,"4, GW-5638",CC/C(=C(\c1ccccc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1,Drug metabolism,'=',0.0,%,,,,UO_0000187,,,,,0,CHEMBL3583331,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (E)-3-(4-((E)-1-(3-hydroxyphenyl)-2-phenylbut-1-enyl)phenyl)acrylic acid formation at 4 uM preincubated for 10 mins followed by addition of NADPH regenerating system measured after 4 hrs by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580562,1,Scientific Literature,J Med Chem,2015,,,,,0.0
CHEMBL3288136,,,414.82,0.0,4.12,2,COc1ccc(Cl)cc1NC(=O)N1CCN(c2ncccc2C(F)(F)F)CC1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3291846,Drug metabolism in rat liver microsomes assessed as hydrolysis into primary urea,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3286122,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3342553,,,484.53,0.0,1.93,5,CNC(=O)O[C@H]1COc2ccc(N3CCN(C4COC4)CC3)cc2[C@@H]1NC(=O)c1ccc(F)cc1,Drug metabolism,'<',20.0,%,,,,UO_0000187,,,,,0,CHEMBL3387380,Drug metabolism in rat liver microsomes after 30 mins at 4 uM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351795,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,20.0
CHEMBL3527204,,,334.77,0.0,1.31,"M7, 5-hydroxymethyl BIIB021, CF3785",COc1c(CO)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C,Drug metabolism,'=',53.2,%,,,,UO_0000187,,,,,0,CHEMBL3536546,Drug level in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity treated with [14C]BIIB021 at 10 uM after 90 mins by LC-RAM-MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,53.2
CHEMBL3613364,,,500.96,1.0,3.53,18,CN(C)C(=O)Cc1nn(-c2ccc(OCCOCCF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',11.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,11.0
CHEMBL3613370,,,450.9,0.0,3.6,31,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2CC#CCF,Drug metabolism,'=',26.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,26.0
CHEMBL3613372,,,514.99,1.0,3.63,33,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2CCOCCOCCF,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535681,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N-ethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5-(hydroxymethyl)-7-methylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3622209,,,344.4,0.0,2.57,12,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622210,,,378.4,0.0,3.46,13,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3414925,,,403.42,0.0,4.54,(S)-21e,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418538,Drug metabolism in rat liver microsomes assessed as metabolite M3 formation in presence of NADPH by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL2177904,,,381.41,0.0,3.69,(S)-25,NC1=N[C@](c2ccncc2)(c2cccc(-c3cncnc3)c2)c2cccc(F)c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531283,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as 4-(3-amino-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-1-yl)pyridine 1-oxide formation at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3527205,,,334.77,0.0,1.84,"M10, CF2483",COc1c(C)cnc(Cn2c(O)nc3c(Cl)nc(N)nc32)c1C,Drug metabolism,'=',1.3,%,,,,UO_0000187,,,,,0,CHEMBL3536546,Drug level in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity treated with [14C]BIIB021 at 10 uM after 90 mins by LC-RAM-MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,1.3
CHEMBL3527358,PPI-2458,1.0,424.54,0.0,2.3,PPI-2458,CO[C@@H]1[C@H](OC(=O)N[C@@H](C(N)=O)C(C)C)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3541127,"Metabolic stability in rat liver microsomes assessed as retention time of ((3R,4S,5S,6R)-4-((2R,3R)-3-((E)-4-hydroxy-3-methylbut-2-en-1-yl)-2-methyloxiran-2-yl)-5-methoxy-1-oxaspiro[2.5]octan-6-yl((R)-1-amino-3-methyl-1-oxobutan-2-yl)carbamate) at 5 mM by LC/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526018,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL4106201,,,514.66,1.0,4.34,GD,CC(CC(=O)CC(C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535532,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (6R)-6-((5R,7S,10S,13R,14R,17R)-2,7-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid formation at 100 uM after 1 hr by by UPLC/Q-TOF analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526082,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL4106202,,,516.68,1.0,4.13,M1,CC(CC(=O)CC(C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535534,Drug level in Sprague-Dawley rat liver microsomes assessed as compound formation treated with ganoderic acid D at 100 uM after 1 hr by UPLC/Q-TOF analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526082,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3622207,,,343.41,0.0,2.0,10,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627508,Drug metabolism in rat liver microsomes assessed as glutathione conjugates,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3125936,,,354.36,0.0,2.22,"3, HFI-419",CCOC(=O)C1=C(NC(C)=O)Oc2cc(O)ccc2C1c1cccnc1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3130737,Drug metabolism in rat liver microsomes assessed as deacetylation to HFI-142 at 1 uM by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3124862,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3586309,,,402.52,1.0,5.37,1,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3588449,Drug metabolism in rat liver microsomes at 10 uM by LC-MS/reverse phase HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3585259,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3809829,,,431.54,1.0,5.02,34h,COc1cc(-c2cnn(C)c2)ccc1Nc1ncc2ccnc(N[C@@H](C)C(C)(C)C)c2n1,Drug metabolism,'=',24.0,%,,,,UO_0000187,,,,,0,CHEMBL3811856,Drug metabolism in Sprague-Dawley rat liver microsomes at 10 uM after 30 mins by LCMS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3808337,1,Scientific Literature,J Med Chem,2016,,,,,24.0
CHEMBL3622210,,,378.4,0.0,3.46,13,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627508,Drug metabolism in rat liver microsomes assessed as glutathione conjugates,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3580776,,,385.41,0.0,2.69,18a,N[C@@H](CC(=O)N1CC(=O)Nc2ccccc2C1)[C@H]1CCc2cc(F)c(F)cc21,Drug metabolism,'=',50.0,%,,,,UO_0000187,,,,,0,CHEMBL3582608,Metabolic stability in rat liver microsome assessed as turnover after 84 mins,A,BAO_0000251,microsome format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580611,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,50.0
CHEMBL3613371,,,470.93,0.0,3.61,32,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2CCOCCF,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL2181754,,,435.44,0.0,4.77,1,CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)C1CC1,Drug metabolism,'=',21.0,%,,,,UO_0000187,,,,,0,CHEMBL3377772,Drug metabolism in rat liver microsomes assessed as phase-2 metabolism measured by glucuronidation level at 5 uM in presence of UDPGA after 2 hrs at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,21.0
CHEMBL866,MYCOPHENOLIC ACID,4.0,320.34,0.0,2.73,MPA,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,Drug metabolism,'=',30.0,%,,,,UO_0000187,,,,,0,CHEMBL3590809,Drug metabolism in rat liver microsomes assessed as glucuronide formation at 600 uM incubated for 30 mins in presence of UDPGA by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3588789,1,Scientific Literature,J Med Chem,2015,,,,,30.0
CHEMBL3527578,,,331.59,0.0,5.0,6-OH-TCC,O=C(Nc1ccc(Cl)cc1)Nc1cc(Cl)c(Cl)cc1O,Drug metabolism,'=',5500.0,pmol/min/mg,,,,,,,,,0,CHEMBL3531134,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as glucuronidation incubated for 5 mins prior to UDPGA addition measured after 5 to 30 mins by LC-UV analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525967,1,Scientific Literature,Drug Metab Dispos,2012,,,,,5500.0
CHEMBL3526914,,,389.45,0.0,4.94,M2,COc1cc(C(O)c2cccc(-c3cc4ccccc4[nH]3)c2)cc(OC)c1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540735,Drug level in rat liver microsomes assessed as compound retention time treated with 0.5 uM I-387 after 2 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526142,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3218260,,,437.52,0.0,3.45,4,COCCn1cc(C(=O)N2CCC3(CC2)COc2ccc(CN)cc23)c2cccc(F)c21,Drug metabolism,'=',10.0,%,,,,UO_0000187,,,,,0,CHEMBL3225064,Drug metabolism in rat liver microsomes after 20 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3217425,1,Scientific Literature,Medchemcomm,2011,,,,,10.0
CHEMBL3526208,,,383.43,0.0,2.75,M12,Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccc(O)cc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540524,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3542241,,,284.32,0.0,1.7,DPH-124921,COc1ccc(-c2c(C)nn3c(N)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530623,Drug metabolism in rat liver microsomes assessed as DPH-124921 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3401200,,,352.37,0.0,3.34,4f,Cc1nc(N2CCc3nc(COc4ccccc4)cn3C2=O)ccc1F,Drug metabolism,'=',93.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,93.0
CHEMBL3527203,,,300.32,0.0,1.18,M6,COc1c(C)cnc(Cn2cnc3c(O)nc(N)nc32)c1C,Drug metabolism,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL3536546,Drug level in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity treated with [14C]BIIB021 at 10 uM after 90 mins by LC-RAM-MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,0.6
CHEMBL427202,,,370.38,0.0,3.52,(S)-brivanib,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1,Drug metabolism,'=',13.8,%,,,,UO_0000187,,,,,0,CHEMBL3534813,Drug level in rat liver microsomes assessed as compound formation treated with 2 uM [14C]brivanib alaninate after 60 mins by LC/MS method in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,13.8
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3528590,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 2-mercapto-3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)propanamide at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540532,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 5-(4-((6-methoxy-1H-benzo[d]imidazol-2-yl)methoxy)benzyl)thiazolidine-2,4-dione at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3794184,,,355.79,0.0,2.81,18,[2H]C([2H])([2H])OC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3795972,Drug metabolism in rat liver microsomes assessed as position 4/6 CH3 cleavage by LC-MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3792375,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL3613359,,,456.91,0.0,3.51,13,CN(C)C(=O)Cc1nn(-c2ccc(OCCF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',2.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,2.0
CHEMBL3613365,,,545.01,1.0,3.54,19,CN(C)C(=O)Cc1nn(-c2ccc(OCCOCCOCCF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',52.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,52.0
CHEMBL2414256,,,470.41,1.0,5.07,3e,CC(C)(C)n1nnnc1C(NCCNc1ccnc2cc(Cl)ccc12)c1ccc(Cl)cc1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3100379,Drug metabolism in rat liver microsomes assessed as 4-(2-((1-tert-butyl-1H-tetrazol-5-yl)(4-chlorophenyl)methylamino)ethylamino)-7-chloroquinoline 1-oxide level at 5 uM after 1 hr by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3098028,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,
CHEMBL3526727,,,430.48,0.0,2.14,M6a,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(CO)cc(CO)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3526252,,,368.37,0.0,3.73,M31,CC(=O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534813,Drug level in rat liver microsomes assessed as compound formation treated with 2 uM [14C]brivanib alaninate after 60 mins by LC/MS method in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3527054,,,356.42,0.0,4.37,(S)-Sulindac,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S@+](C)[O-])cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3528159,Drug metabolism in rat liver microsomes assessed as sulindac sulfone formation at 20 nM after 60 mins by HPLC analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525907,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3542290,,,547.49,0.0,4.63,AZD3839,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21.O=C(O)/C=C/C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534880,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (S)-5-(3-(3-amino-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1H-isoindol-1-yl)phenyl)pyrimidine 1-oxide formation at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3542290,,,547.49,0.0,4.63,AZD3839,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21.O=C(O)/C=C/C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534879,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (S)-4-(3-amino-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-1-yl)-2-(difluoromethyl)pyridine 1-oxide formation at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3526913,,,387.44,1.0,5.09,I-387,COc1cc(C(=O)c2cccc(-c3cc4ccccc4[nH]3)c2)cc(OC)c1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540734,"Drug metabolism in rat liver microsomes assessed as (3-(1H-indol-2-yl)phenyl)(3,4,5-trimethoxyphenyl)methanol formation at 0.5 uM after 2 hrs by LC-MS/MS analysis in presence of 3 mM NADPH",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526142,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3622205,,,343.41,0.0,2.0,8,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622209,,,344.4,0.0,2.57,12,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627508,Drug metabolism in rat liver microsomes assessed as glutathione conjugates,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622697,,,380.38,0.0,3.43,14,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627508,Drug metabolism in rat liver microsomes assessed as glutathione conjugates,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3753093,,,373.54,0.0,3.15,2a,CC(C)N1CCC(Oc2ccc(C(=O)NC3CCN(C(C)C)C3)cc2)CC1,Drug metabolism,'=',4.0,%,,,,UO_0000187,,,,,0,CHEMBL3755250,Metabolic stability in rat liver microsomes assessed as compound metabolized after 30 mins by LC-MS/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3751729,1,Scientific Literature,Eur J Med Chem,2016,,,,,4.0
CHEMBL3613362,,,482.94,0.0,4.07,16,CN(C)C(=O)Cc1nn(-c2ccc(OC/C=C/CF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',41.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,41.0
CHEMBL3613358,,,424.89,0.0,3.17,11,COc1ccc(-n2nc(CC(=O)N(C)C)c3c4ccc(Cl)cc4n(C)c3c2=O)cc1,Drug metabolism,'=',4.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,4.0
CHEMBL3092215,,,504.55,1.0,3.03,22,CN(C1CCN(C(=O)c2ccccc2S(C)(=O)=O)CC1)S(=O)(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.08,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.08
CHEMBL3401181,,,332.36,0.0,2.77,3i,Cc1ccc(-n2ccc3nc(COc4ccccc4)cn3c2=O)nc1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401202,,,355.34,0.0,3.77,4i,O=C1N(c2ccc(F)cc2)CCc2nc(COc3ccc(F)cc3)cn21,Drug metabolism,'=',11.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,11.0
CHEMBL3401174,,,255.28,0.0,1.61,3b,Cn1ccc2nc(COc3ccccc3)cn2c1=O,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401178,,,335.34,0.0,3.2,3f,O=c1n(-c2cccc(F)c2)ccc2nc(COc3ccccc3)cn12,Drug metabolism,'=',71.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,71.0
CHEMBL3401185,,,350.35,0.0,2.91,3m,Cc1nc(-n2ccc3nc(COc4ccccc4)cn3c2=O)ccc1F,Drug metabolism,'=',50.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,50.0
CHEMBL3401194,,,349.37,0.0,3.51,3v,Cc1cn(-c2ccc(F)cc2)c(=O)n2cc(COc3ccccc3)nc12,Drug metabolism,'=',71.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,71.0
CHEMBL3823817,,,408.53,0.0,4.03,(+)-23,C[C@@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccc(CCC(C)(C)O)cn2)n1,Drug metabolism,'=',43.7,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,43.7
CHEMBL1650002,,,352.35,0.0,1.76,M1,CO/N=C(/N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/O)cn3)o2)nc1,Drug metabolism,'=',45.0,%,,,,UO_0000187,,,,,0,CHEMBL3536992,Drug level in rat liver microsomes treated with 10 uM DB868 prodrug after 180 mins incubation by HPLC-UV chromatography relative to initial prodrug concentration,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525966,1,Scientific Literature,Drug Metab Dispos,2013,,,,,45.0
CHEMBL145118,,,338.33,0.0,1.59,M2,N/C(=N\O)c1ccc(-c2ccc(-c3ccc(/C(N)=N\O)cn3)o2)nc1,Drug metabolism,'<',3.0,%,,,,UO_0000187,,,,,0,CHEMBL3536992,Drug level in rat liver microsomes treated with 10 uM DB868 prodrug after 180 mins incubation by HPLC-UV chromatography relative to initial prodrug concentration,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525966,1,Scientific Literature,Drug Metab Dispos,2013,,,,,3.0
CHEMBL3622206,,,342.42,0.0,2.6,9,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3613368,,,454.93,0.0,4.37,29,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2CCCCF,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL3582294,,,428.44,0.0,4.78,22e,CNC(=O)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3583095,"Drug formation in Sprague-Dawley rat liver microsomes treated with 2-Fluoro-4-(8-fluoro-3-(quinolin-6-ylmethyl)imidazo[1,2-a]pyridin-6-yl)-N-methylbenzamide after 60 mins by UPLC/Q-TOF MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580555,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL165676,,,464.48,0.0,3.88,15,COc1ccc([C@H]2Cc3c(cccc3C(F)(F)F)N(CCN(C)C)C(=O)[C@H]2OC(C)=O)cc1,Drug metabolism,'=',53.0,%,,,,UO_0000187,,,,,0,CHEMBL3134875,Drug metabolism in rat liver microsomes assessed as oxidative deamination,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3132812,1,Scientific Literature,Medchemcomm,2013,,,,,53.0
CHEMBL3526583,,,414.48,0.0,2.96,M4,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(CO)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3401196,,,337.35,0.0,3.63,4b,O=C1N(c2cccc(F)c2)CCc2nc(COc3ccccc3)cn21,Drug metabolism,'=',78.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,78.0
CHEMBL1277687,CERATAMINE A,,468.15,0.0,3.45,Ceratamine A,CNc1nc2ccn(C)c(=O)c(Cc3cc(Br)c(OC)c(Br)c3)c-2n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3372680,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine A for 60 mins assessed as metabolite formation in presence of 1 mM NADPH at pH 7.4 and 37 degC by reverse phase HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,
CHEMBL3526777,,,274.36,0.0,2.59,M3,Cc1cc(C(C)(C)CO)c(O)c(C)c1Cc1ncc[nH]1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540538,Drug level in NADPH supplemented rat liver microsomes fraction treated with 50 uM oxymetazoline assessed as compound formation after 1 hr by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525902,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL2177904,,,381.41,0.0,3.69,(S)-25,NC1=N[C@](c2ccncc2)(c2cccc(-c3cncnc3)c2)c2cccc(F)c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531575,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as GSH conjugate formation at 10 uM by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3337456,,,347.46,0.0,3.9,18,N#Cc1c(N2CCC(c3ccccc3)CC2)ccn(CC2CCC2)c1=O,Drug metabolism,'=',86.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,86.0
CHEMBL3734988,,,469.44,0.0,3.05,42,C[C@@H](O)c1nc2cnc(Nc3ccnc(N4CC[C@H](O)[C@H](F)C4)n3)cc2n1[C@H](C)C(F)(F)F,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3737834,"Drug level in rat liver microsomes treated with (R)-1-[6-[2-(cis-3-Fluoro-4-methoxypiperidin-1-yl)pyrimidin-4-ylamino]-1-((S)-2,2,2-trifluoro-1-methylethyl)-1H-imidazo[4,5-c]pyridin-2-yl]ethanol",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3734664,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535680,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-bis(hydroxymethyl)pyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3527118,,,414.48,0.0,2.96,M1,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(CO)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535676,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-6-hydroxy-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3542242,,,285.31,0.0,1.83,BMS-572273,COc1ccc(-c2c(C)nn3c(O)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530613,Drug metabolism in rat liver microsomes at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3092219,,,598.59,1.0,4.44,26,CS(=O)(=O)c1ccc(C(=O)N2CCC3(CCN(S(=O)(=O)c4cccc(C(F)(F)F)c4)CC3)C2)c(C(F)(F)F)c1,Drug metabolism,'=',0.18,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.18
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',20.25,%,,,,UO_0000187,,,,,0,CHEMBL3257800,Drug metabolism in Wistar rat liver microsomes assessed as total cis-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,20.25
CHEMBL30678,,,321.43,0.0,3.12,6,CN(C)c1ccc(-c2cc3ncccc3c(NCCCN)n2)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622206,,,342.42,0.0,2.6,9,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622697,,,380.38,0.0,3.43,14,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622206,,,342.42,0.0,2.6,9,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627508,Drug metabolism in rat liver microsomes assessed as glutathione conjugates,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3262309,,,367.41,0.0,4.19,M6,c1cnc(OCCc2cnc3[nH]c4ccccc4c3c2)c(-c2cncnc2)c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265940,"Metabolic stability in rat liver microsomes assessed as metabolite M9 (9-methyl-3-(2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)vinyl)-9H-pyrido[2,3-b]indole) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265938,"Metabolic stability in rat liver microsomes assessed as metabolite M7 (9-methyl-3-(2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)vinyl)-9H-pyrido[2,3-b]indole) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265939,"Metabolic stability in rat liver microsomes assessed as metabolite M8 (1-(9-methyl-9H-pyrido[2,3-b]indol-3-yl)-2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)ethanol) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3236002,,,409.45,0.0,3.01,17,CC(C)(C)OC(=O)NCc1noc(-c2c3ccccc3nn2CCn2ccnc2)n1,Drug metabolism,'=',70.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,70.0
CHEMBL3542241,,,284.32,0.0,1.7,DPH-124921,COc1ccc(-c2c(C)nn3c(N)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530613,Drug metabolism in rat liver microsomes at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3325627,,,472.55,1.0,5.07,50c,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C,Drug metabolism,'=',2.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,2.0
CHEMBL3337509,,,335.45,0.0,3.76,17,CC(C)Cn1ccc(N2CCC(c3ccccc3)CC2)c(C#N)c1=O,Drug metabolism,'=',47.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,47.0
CHEMBL3337501,,,321.42,0.0,3.33,9,CC(C)CCn1ccc(N2CCc3ccccc3C2)c(C#N)c1=O,Drug metabolism,'=',100.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,100.0
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',55.38,%,,,,UO_0000187,,,,,0,CHEMBL3257802,Drug metabolism in Wistar rat liver microsomes assessed as total cis-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,55.38
CHEMBL3741934,,,449.28,0.0,4.67,10,COc1cc(Br)c(NC(=O)N2C=CC(=O)C[C@H]2c2ccc(F)cc2)cc1OC,Drug metabolism,'=',33.0,%,,,,UO_0000187,,,,,0,CHEMBL3743583,"Drug metabolism in rat liver microsomes assessed as GSH adduct UV peak area at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC/MS/MS analysis relative to total area of GSH adduct, other metabolites, parent compound",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3739255,1,Scientific Literature,J Med Chem,2015,,,,,33.0
CHEMBL3741992,,,418.85,0.0,3.28,15,Cc1cc(Cl)c(OCCO)cc1NC(=O)C1=CNC(=O)C[C@H]1c1ccc(F)cc1,Drug metabolism,,,,,,BLD,,,,,,0,CHEMBL3743583,"Drug metabolism in rat liver microsomes assessed as GSH adduct UV peak area at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC/MS/MS analysis relative to total area of GSH adduct, other metabolites, parent compound",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3739255,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3542192,,,298.41,0.0,0.89,B12,CC(C)(O)[C@]1(C)SC(N[C@H]2C[C@H]3C[C@@H]2[C@H](O)C3)=NC1=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3539085,"Drug level in rat liver microsomes treated with (S)-2-((1S,2S,4R,6R)-6-hydroxybicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525943,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3527054,,,356.42,0.0,4.37,(S)-Sulindac,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S@+](C)[O-])cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3528159,Drug metabolism in rat liver microsomes assessed as sulindac sulfone formation at 20 nM after 60 mins by HPLC analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525907,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540521,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 5-(4-((6-hydroxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)benzyl)thiazolidine-2,4-dione at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3325807,,,533.03,1.0,4.02,52j,CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',47.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,47.0
CHEMBL3337521,,,369.42,0.0,3.79,30,N#Cc1c(N2CCC(c3ccc(F)cc3F)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',34.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,34.0
CHEMBL3099820,,,504.85,2.0,5.73,3d,CC(C)(C)n1nnnc1C(NCCNc1ccnc2cc(Cl)ccc12)c1ccc(Cl)c(Cl)c1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3100379,Drug metabolism in rat liver microsomes assessed as 4-(2-((1-tert-butyl-1H-tetrazol-5-yl)(4-chlorophenyl)methylamino)ethylamino)-7-chloroquinoline 1-oxide level at 5 uM after 1 hr by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3098028,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,
CHEMBL3414926,,,447.47,0.0,4.56,(S)-21f,COCCOc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414926,,,447.47,0.0,4.56,(S)-21f,COCCOc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418546,"Drug metabolism in rat liver microsomes assessed as formation of (S)-2-(6-(1-(8-fluoro-6-(3-methylisoxazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)quinolin-3-yloxy)acetic acid in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3262307,,,395.42,0.0,3.87,M4,Cn1c2ccccc2c2cc(/C=C/Oc3ncccc3-c3cncnc3)c[n+]([O-])c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3529159,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 2-hydroxy-3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)propanamide at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL2105653,SETILEUTON,2.0,463.39,0.0,4.75,Setileuton,CC[C@](O)(c1nnc(NCc2ccc3c(-c4ccc(F)cc4)cc(=O)oc3c2)o1)C(F)(F)F,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530466,Drug metabolism in NADPH fortified rat liver microsomes assessed as N-((4-(4-fluorophenyl)-2-oxochroman-7-yl)methyl)-2-((S)-2-hydroxy-2-(trifluoromethyl)butanoyl)hydrazinecarboxamide level,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526019,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527358,PPI-2458,1.0,424.54,0.0,2.3,PPI-2458,CO[C@@H]1[C@H](OC(=O)N[C@@H](C(N)=O)C(C)C)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3541126,"Metabolic stability in rat liver microsomes assessed as retention time of ((3R,4S,5S,6R)-4-((2R,3R)-3-(((S)-3,3-dimethyloxiran-2-yl)methyl)-2-methyloxiran-2-yl)-5-methoxy-1-oxaspiro[2.5]octan-6-yl ((R)-1-amino-3-methyl-1-oxobutan-2-yl)carbamate) at 5 mM by LC/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526018,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3403744,,,394.76,1.0,5.44,9b,Cn1nc(C(F)(F)F)cc1-c1cnc2[nH]c(-c3c(F)cccc3Cl)cc2c1,Drug metabolism,'<',5.0,%,,,,UO_0000187,,,,,0,CHEMBL3405052,Drug metabolism in rat liver microsomes at 5 uM after 30 mins in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399948,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,5.0
CHEMBL3325894,,,568.12,1.0,3.54,52ae,CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C,Drug metabolism,'=',13.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,13.0
CHEMBL3355467,,,450.99,0.0,2.96,25,[2H]C1([2H])c2c(C3CCN(S(C)(=O)=O)CC3)cnn2C[C@@H](C)N1c1cc(Cl)nc2[nH]ccc12,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3372396,Metabolic stability in rat liver microsomes assessed as level of cyanide adduct after 60 mins at 20 uM by cyanide trapping assay,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351372,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL3325891,,,563.06,1.0,3.59,"52w, SAR216471",CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C,Drug metabolism,'=',11.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,11.0
CHEMBL3337508,,,335.45,0.0,3.9,16,CCCCn1ccc(N2CCC(c3ccccc3)CC2)c(C#N)c1=O,Drug metabolism,'=',62.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,62.0
CHEMBL3337511,,,347.46,0.0,3.9,20,N#Cc1c(N2CCC(c3ccccc3)CC2)ccn(CCC2CC2)c1=O,Drug metabolism,'=',61.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,61.0
CHEMBL3092209,,,562.61,1.0,4.1,16,CC1(N(C2CC2)S(=O)(=O)c2cccc(C(F)(F)F)c2)CCN(C(=O)c2cc(F)ccc2S(C)(=O)=O)CC1,Drug metabolism,'=',0.06,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.06
CHEMBL3799908,,,393.49,0.0,3.87,6,COc1cc(C)c(CNCC(NC(=O)c2cc(C)on2)c2ccccc2)cc1C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3803914,Drug metabolism in rat liver microsomes assessed as O-dealkylated metabolite formation after 60 mins by LC/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3797080,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,
CHEMBL3740434,,,453.7,1.0,5.31,12,COc1cc(NC(=O)N2C=CC(=O)C[C@H]2c2ccc(F)cc2)c(Br)cc1Cl,Drug metabolism,'=',16.0,%,,,,UO_0000187,,,,,0,CHEMBL3743583,"Drug metabolism in rat liver microsomes assessed as GSH adduct UV peak area at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC/MS/MS analysis relative to total area of GSH adduct, other metabolites, parent compound",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3739255,1,Scientific Literature,J Med Chem,2015,,,,,16.0
CHEMBL3323181,,,364.51,0.0,4.32,10i,CN1Cc2cc(N3CCOCC3)ccc2[C@@H](c2ccc3sccc3c2)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3379387,"Drug metabolism in rat liver microsomes assessed as formation of (+)-2-(4-(benzo[b]thiophen-5-yl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ylamino)ethanol",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351632,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,
CHEMBL3401190,,,336.33,0.0,2.6,3r,O=c1n(-c2ccc(F)cc2)ccc2nc(COc3ccccn3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401193,,,349.37,0.0,3.51,3u,Cc1cc2nc(COc3ccccc3)cn2c(=O)n1-c1ccc(F)cc1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401198,,,338.34,0.0,3.03,4d,O=C1N(c2ccc(F)cn2)CCc2nc(COc3ccccc3)cn21,Drug metabolism,'=',14.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,14.0
CHEMBL3401203,,,351.38,0.0,3.94,4j,Cc1cccc(OCc2cn3c(n2)CCN(c2ccc(F)cc2)C3=O)c1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3781527,,,861.86,2.0,3.8,3; 3FDT,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)C12)C3(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3783100,Drug metabolism in rat liver microsomes assessed as metabolite M2 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3779870,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL3115061,,,398.25,0.0,1.91,38,Cl.O=C1N[C@H](C(=O)O)Cc2cn(cn2)C/C=C/COc2ccc(Cl)c1c2,Drug metabolism,'=',0.0,%,,,,UO_0000187,,,,,0,CHEMBL3116949,Drug metabolism in Sprague-Dawley rat liver microsomes at 5 uM after 20 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112421,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,0.0
CHEMBL3527358,PPI-2458,1.0,424.54,0.0,2.3,PPI-2458,CO[C@@H]1[C@H](OC(=O)N[C@@H](C(N)=O)C(C)C)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3541125,"Metabolic stability in rat liver microsomes assessed as retention time of ((3R,4S,5S,6R)-4-((2R,3R)-3-(((R)-3,3-dimethyloxiran-2-yl)methyl)-2-methyloxiran-2-yl)-5-methoxy-1-oxaspiro[2.5]octan-6-yl ((R)-1-amino-3-methyl-1-oxobutan-2-yl)carbamate) at 5 mM by LC/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526018,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3527358,PPI-2458,1.0,424.54,0.0,2.3,PPI-2458,CO[C@@H]1[C@H](OC(=O)N[C@@H](C(N)=O)C(C)C)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3541124,"Metabolic stability in rat liver microsomes assessed as retention time of ((3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl ((R)-1-amino-3-hydroxy-3-methyl-1-oxobutan-2-yl)carbamate) at 5 mM by LC/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526018,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3526621,,,386.38,0.0,2.7,M7,Cc1c(OC[C@@H](C)O)cn2ncnc(Oc3ccc4[nH]c(CO)cc4c3F)c12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534813,Drug level in rat liver microsomes assessed as compound formation treated with 2 uM [14C]brivanib alaninate after 60 mins by LC/MS method in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542284,,,654.88,2.0,2.27,"M3-6, 26,27-dihydroxy Rh2",CC1(C)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C[C@@H](O)[C@@H]4[C@@H]([C@@](C)(O)CCC=C(CO)CO)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL427202,,,370.38,0.0,3.52,(S)-brivanib,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3534831,"Drug metabolism in rat liver microsomes assessed as (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-ol formation at 10 uM after 60 mins by LC/MS analysis in absence of NADPH",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL4106201,,,514.66,1.0,4.34,GD,CC(CC(=O)CC(C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535533,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (6R)-6-((5R,7S,10S,13R,14R,17R)-2,7-dihydroxy-4-(hydroxymethyl)-4,10,13,14-tetramethyl-3,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid formation at 100 uM after 1 hr by by UPLC/Q-TOF analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526082,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526911,,,320.76,0.0,2.13,[14C]BIIB021,COc1c(C)cnc(Cn2[14cH]nc3c(Cl)nc(N)nc32)c1C,Drug metabolism,'=',34.1,%,,,,UO_0000187,,,,,0,CHEMBL3536552,Drug metabolism in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity at 10 uM after 90 mins by LC-RAM-MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,34.1
CHEMBL3401182,,,332.36,0.0,2.77,3j,Cc1cccc(-n2ccc3nc(COc4ccccc4)cn3c2=O)n1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622207,,,343.41,0.0,2.0,10,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622210,,,378.4,0.0,3.46,13,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622698,,,380.38,0.0,3.43,15,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3218259,,,427.5,0.0,4.04,3,COCCn1cc(C(=O)N2CCC(c3cc(CN)ccc3F)CC2)c2cccc(F)c21,Drug metabolism,'=',21.0,%,,,,UO_0000187,,,,,0,CHEMBL3225064,Drug metabolism in rat liver microsomes after 20 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3217425,1,Scientific Literature,Medchemcomm,2011,,,,,21.0
CHEMBL3823394,,,382.45,0.0,2.69,(-)-25; LY3130481,C[C@@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccc(OCCO)cn2)n1,Drug metabolism,'=',32.3,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,32.3
CHEMBL3582294,,,428.44,0.0,4.78,22e,CNC(=O)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3583087,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as 2-Fluoro-4-(8-fluoro-3-(hydroxy(quinolin-6-yl)methyl)imidazo[1,2-a]pyridin-6-yl)-N-methylbenzamide metabolite formation after 60 mins by UPLC/Q-TOF MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580555,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL3416644,,,365.43,0.0,3.79,2-2,COc1ccc2c(c1)O/C(=C\c1ccc(OCCN3CCCC3)cc1)C2=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418421,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of monohydroxylated metabolite at 2 uM at pH 7.4 pre-incubated in presence of NADPH regenerating system measured after 10 to 30 mins by LC-MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414445,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL3126105,,,620.77,1.0,4.25,19a,COc1ccc2c(c1)[C@@H]1C[C@]13Cn1c-2c(C2CCCCC2)c2ccc(cc21)C(=O)NS(=O)(=O)N(C)CCOCCN(C)C3=O,Drug metabolism,'=',70.0,%,,,,UO_0000187,,,,,0,CHEMBL3131834,Drug metabolism in rat liver microsomes after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3124872,1,Scientific Literature,J Med Chem,2014,,,,,70.0
CHEMBL3325789,,,556.67,1.0,4.15,52g,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C,Drug metabolism,'=',63.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,63.0
CHEMBL3325793,,,575.11,2.0,5.11,52o,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C,Drug metabolism,'=',23.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,23.0
CHEMBL3622204,,,342.42,0.0,2.6,7,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3628404,,,436.56,0.0,4.34,31,C[S+]([O-])c1ccc(-c2cnn3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)cc23)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3631993,"Drug metabolism in rat liver microsomes assessed as 5-(3-(Cyclopropylsulfonyl)phenyl)-3-(4-(methylsulfonyl)-phenyl)pyrazolo[1,5-a]pyridine formation at 10 uM after 1 hr by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3627607,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3774670,,,539.4,2.0,5.47,M538a,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3ccc(O)c(F)c3)c3ccc4[nH]c(C)nc4c3)c(Cl)c2)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3778025,"Drug level in Sprague-Dawley rat liver microsomes treated with (R)-2,6-Dichloro-N-(2-(3-fluorophenyl)-2-(2-methyl-1Hbenzo[d]imidazol-5-yl)ethyl)-4-(3-methyl-1H-1,2,4-triazol-1-yl)-benzamide after 4 hrs by LC-MS/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3774356,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3774998,,,539.4,1.0,4.95,M538b,Cc1nc2cc([C@@H](CNC(=O)c3c(Cl)cc(-n4cnc(CO)n4)cc3Cl)c3cccc(F)c3)ccc2[nH]1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3778025,"Drug level in Sprague-Dawley rat liver microsomes treated with (R)-2,6-Dichloro-N-(2-(3-fluorophenyl)-2-(2-methyl-1Hbenzo[d]imidazol-5-yl)ethyl)-4-(3-methyl-1H-1,2,4-triazol-1-yl)-benzamide after 4 hrs by LC-MS/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3774356,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3741412,,,418.85,0.0,4.22,13,Cc1cc(Cl)c(OCCO)cc1NC(=O)N1C=CC(=O)C[C@H]1c1ccc(F)cc1,Drug metabolism,'=',5.0,%,,,,UO_0000187,,,,,0,CHEMBL3743583,"Drug metabolism in rat liver microsomes assessed as GSH adduct UV peak area at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC/MS/MS analysis relative to total area of GSH adduct, other metabolites, parent compound",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3739255,1,Scientific Literature,J Med Chem,2015,,,,,5.0
CHEMBL3323187,,,338.48,0.0,3.88,13,CN1Cc2cc(NCCO)ccc2C(c2ccc3sccc3c2)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3379389,Drug metabolism in rat liver microsomes treated with AMR-2,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351632,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,
CHEMBL2181754,,,435.44,0.0,4.77,1,CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)C1CC1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3377770,Drug metabolism in rat liver microsomes at 5 uM in presence of NADPH after 30 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3338145,,,444.45,1.0,5.17,26,CCN(Cc1cc(C(F)(F)F)ccc1-c1cn(CC(=O)O)c2ccccc12)C(=O)C1CC1,Drug metabolism,'<',5.0,%,,,,UO_0000187,,,,,0,CHEMBL3377770,Drug metabolism in rat liver microsomes at 5 uM in presence of NADPH after 30 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,5.0
CHEMBL3338144,,,445.44,0.0,4.57,25,CCN(Cc1cc(C(F)(F)F)ccc1-c1nn(CC(=O)O)c2ccccc12)C(=O)C1CC1,Drug metabolism,'=',12.0,%,,,,UO_0000187,,,,,0,CHEMBL3377772,Drug metabolism in rat liver microsomes assessed as phase-2 metabolism measured by glucuronidation level at 5 uM in presence of UDPGA after 2 hrs at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,12.0
CHEMBL3338149,,,445.44,0.0,4.43,30,CCN(Cc1cc(C(F)(F)F)ccc1-n1cc(CC(=O)O)c2cccnc21)C(=O)C1CC1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3377770,Drug metabolism in rat liver microsomes at 5 uM in presence of NADPH after 30 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3613363,,,480.93,0.0,3.51,17,CN(C)C(=O)Cc1nn(-c2ccc(OCC#CCF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',25.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,25.0
CHEMBL3092216,,,524.48,1.0,4.92,23,CCN(C1CCN(C(=O)c2ccccc2OC(F)(F)F)CC1)S(=O)(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.08,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.08
CHEMBL3622210,,,378.4,0.0,3.46,13,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3355468,,,452.0,0.0,2.96,26,[2H]C1([2H])c2c(C3CCN(S(C)(=O)=O)CC3)cnn2C[C@@]([2H])(C)N1c1cc(Cl)nc2[nH]ccc12,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3372396,Metabolic stability in rat liver microsomes assessed as level of cyanide adduct after 60 mins at 20 uM by cyanide trapping assay,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351372,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL3823274,,,307.38,0.0,3.85,6,CN(c1ccc2[nH]ncc2c1)c1nc(-c2ccccn2)cs1,Drug metabolism,'=',65.6,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,65.6
CHEMBL3823956,,,290.33,0.0,2.91,7,CN(c1ccc2[nH]ncc2c1)c1ccn(-c2ccccn2)n1,Drug metabolism,'=',32.5,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,32.5
CHEMBL3425534,,,367.84,0.0,4.23,13,Cc1nc2ccncc2n2c(-c3cc(COC(C)C)ccc3Cl)nnc12,Drug metabolism,'=',98.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,98.0
CHEMBL3414738,,,397.38,0.0,4.68,10d,Fc1cc(-c2cscn2)cn2c(C(F)(F)c3ccc4ncccc4c3)nnc12,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414925,,,403.42,0.0,4.54,(S)-21e,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418311,"Drug metabolism in rat liver microsomes assessed as formation of (S)-6-(1-(8-fluoro-6-(3-methylisoxazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)quinolin-3-ol in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414934,,,447.43,0.0,4.0,M7,Cc1cc(-c2cc(F)c3nnc([C@@H](C)c4ccc5ncc(OCC(=O)O)cc5c4)n3c2)on1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3420265,"Drug level in rat liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3356988,,,391.37,0.0,2.7,5(M+14),O=C(Nc1nc2cc(-c3cncc(F)c3)cc(-c3ncccn3)c2[nH]1)NC1CO1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3374111,Drug metabolism in rat liver microsomes assessed as compound formation treated with 30 uM 1-Ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo-[d]imidazol-2-yl)urea for 1 hr,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351508,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3092217,,,570.53,1.0,3.81,24,CS(=O)(=O)c1ccc(C(=O)N2CC(N(C3CC3)S(=O)(=O)c3cccc(C(F)(F)F)c3)C2)c(C(F)(F)F)c1,Drug metabolism,'=',0.04,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.04
CHEMBL3337502,,,349.48,0.0,4.15,10,CC(C)CCn1ccc(N2CCC(c3ccccc3)CC2)c(C#N)c1=O,Drug metabolism,'=',97.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,97.0
CHEMBL3325452,,,561.09,1.0,4.8,52h,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',14.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,14.0
CHEMBL3325791,,,619.56,2.0,5.22,52m,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C,Drug metabolism,'=',20.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,20.0
CHEMBL3357015,,,426.45,0.0,3.36,34(M-2),CC1NC(=O)Nc2nc3c([C@H]4CCCO4)c(F)c(-c4cnc(C(C)(C)O)nc4)cc3n21,Drug metabolism,'<',2.0,%,,,,UO_0000187,,,,,0,CHEMBL3374724,Drug metabolism in rat liver microsomes assessed as compound formation treated with (+)-(R)-1-ethyl-3-(6-fluoro-5-(2-(2-hydroxypropan-2-yl)pyrimidin-5-yl)-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-2-yl)urea for 1 hr,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351508,1,Scientific Literature,J Med Chem,2014,,,,,2.0
CHEMBL3314782,,,440.1,0.0,3.13,M4,CNc1nc2cc[nH]c(=O)c(Cc3cc(Br)c(O)c(Br)c3)c-2n1,Drug metabolism,'=',0.4,%,,,,UO_0000187,,,,,0,CHEMBL3372675,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine A for 60 mins assessed as metabolite abundance in presence of 1 mM NADPH at pH 7.4 and 37 degC by reverse phase HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,0.4
CHEMBL3823441,,,283.36,0.0,3.68,5,CN(c1ccc(O)cc1)c1nc(-c2ccccn2)cs1,Drug metabolism,'=',84.0,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,84.0
CHEMBL3414736,,,395.34,0.0,4.52,10b,Cc1cc(-c2cc(F)c3nnc(C(F)(F)c4ccc5ncccc5c4)n3c2)on1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414739,,,394.36,0.0,3.96,10e,Cn1cc(-c2cc(F)c3nnc(C(F)(F)c4ccc5ncccc5c4)n3c2)cn1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414913,,,425.37,0.0,4.53,12a,COc1cnc2ccc(C(F)(F)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414919,,,420.42,0.0,4.06,(R)-20d,COc1cnc2ccc([C@@](C)(F)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414933,,,433.44,0.0,3.9,M6,Cc1cc(-c2cc(F)c3nnc([C@@H](C)c4ccc5ncc(OCCO)cc5c4)n3c2)on1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3420265,"Drug level in rat liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3781527,,,861.86,2.0,3.8,3; 3FDT,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)C12)C3(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3784224,Drug metabolism in rat liver microsomes assessed as 7-epi-3FDT formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3779870,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL2104148,CLOCOUMAROL,2.0,356.85,1.0,5.21,"1, clocoumarol",CCCC(c1ccc(CCCl)cc1)c1c(O)c2ccccc2oc1=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3253863,"Drug metabolism in Wistar albino rat liver microsomes assessed as formation of 6-[1-Hydroxy-2-oxo-3-[p-(2-chloroethyl)phenyl]hexylidene]-2,4-cyclohexadien-1-one at 5 umol after 30 mins by TLC analysis in presence of NADP/NAD/NADH/oxygen",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3326907,,,458.52,0.0,4.76,50a,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',1.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,1.0
CHEMBL3325631,,,577.13,1.0,4.45,52a,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C.Cl,Drug metabolism,'=',41.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,41.0
CHEMBL3325790,,,579.08,1.0,4.94,52l,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C,Drug metabolism,'=',21.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,21.0
CHEMBL3358430,,,344.42,0.0,2.9,6,CCc1ncccc1Oc1cc(CCCCO)cnc1NC(=O)NC,Drug metabolism,'=',33.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,33.0
CHEMBL3337498,,,294.4,0.0,3.55,6,CC(C)CCn1ccc(CCc2ccccc2)c(C#N)c1=O,Drug metabolism,'=',99.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,99.0
CHEMBL3337504,,,273.38,0.0,2.76,12,CC(C)CCn1ccc(N2CCCCC2)c(C#N)c1=O,Drug metabolism,'=',100.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,100.0
CHEMBL3337514,,,351.42,0.0,3.65,23,N#Cc1c(N2CCC(c3cccc(F)c3)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',37.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,37.0
CHEMBL3337522,,,369.42,0.0,3.79,31,N#Cc1c(N2CCC(c3c(F)cccc3F)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',42.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,42.0
CHEMBL3337523,,,369.42,0.0,3.79,32,N#Cc1c(N2CCC(c3cc(F)cc(F)c3)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',45.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,45.0
CHEMBL3337525,,,376.42,0.0,4.66,34,O=c1c(C(F)(F)F)c(N2CCC(c3ccccc3)CC2)ccn1CC1CC1,Drug metabolism,'=',89.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,89.0
CHEMBL3823445,,,340.38,0.0,3.46,(+)-22,C[C@@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccc(F)cn2)n1,Drug metabolism,'=',67.4,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,67.4
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',1089.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257798,Drug metabolism in Wistar rat liver microsomes assessed as recovered total OH-CCNU derivatives level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,1089.0
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',994.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257798,Drug metabolism in Wistar rat liver microsomes assessed as recovered total OH-CCNU derivatives level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,994.0
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',17.01,%,,,,UO_0000187,,,,,0,CHEMBL3257799,Drug metabolism in Wistar rat liver microsomes assessed as total trans-2-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,17.01
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',18.21,%,,,,UO_0000187,,,,,0,CHEMBL3257800,Drug metabolism in Wistar rat liver microsomes assessed as total cis-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,18.21
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',6.18,%,,,,UO_0000187,,,,,0,CHEMBL3257801,Drug metabolism in Wistar rat liver microsomes assessed as total trans-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,6.18
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',38.3,%,,,,UO_0000187,,,,,0,CHEMBL3257794,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 5 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,38.3
CHEMBL3613367,,,440.91,0.0,3.98,28,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2CCCF,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL3542293,,,326.4,0.0,3.03,DPH-123554,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(O)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530628,Drug metabolism in rat liver microsomes assessed as BMS-572273 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526726,,,352.44,0.0,3.13,M5,CCN(CC)C(=O)Cc1c(-c2ccc(O)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3526549,,,386.43,0.0,2.22,M6b,CCNC(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(CO)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3526243,,,371.46,0.0,2.49,M22,COc1ccc2nc(COc3ccc(CC(S)C(N)=O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540524,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3538332,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of (2S,3S,4S,5R,6R)-6-((1-carboxy-2-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)ethylthio)carbonylamino)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526211,,,417.49,0.0,1.6,M10,COc1ccc2nc(COc3ccc(CC(C(N)=O)S(C)(=O)=O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3538329,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526829,,,401.49,0.0,1.94,M6,COc1ccc2nc(COc3ccc(CC(C(N)=O)[S+](C)[O-])cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3538329,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3740213,,,437.24,0.0,4.8,11,COc1cc(NC(=O)N2C=CC(=O)C[C@H]2c2ccc(F)cc2)c(Br)cc1F,Drug metabolism,'=',37.0,%,,,,UO_0000187,,,,,0,CHEMBL3743583,"Drug metabolism in rat liver microsomes assessed as GSH adduct UV peak area at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC/MS/MS analysis relative to total area of GSH adduct, other metabolites, parent compound",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3739255,1,Scientific Literature,J Med Chem,2015,,,,,37.0
CHEMBL3781527,,,861.86,2.0,3.8,3; 3FDT,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)C12)C3(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3784105,Drug metabolism in rat liver microsomes assessed as metabolite M3 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3779870,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL3822572,,,387.47,0.0,4.15,14,Cn1ccc(CN(c2ccc3[nH]ncc3c2)c2nc(-c3ccccn3)cs2)n1,Drug metabolism,'=',98.5,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,98.5
CHEMBL3618078,,,293.41,0.0,4.49,54,CCc1nc2ccccc2n1CCCCNc1ccccc1,Drug metabolism,'=',99.9,%,,,,UO_0000187,,,,,0,CHEMBL3619165,Metabolic stability of the compound in rat liver microsomes assessed as compound turnover at 2 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3616434,1,Scientific Literature,J Med Chem,2015,,,,,99.9
CHEMBL3414925,,,403.42,0.0,4.54,(S)-21e,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418309,"Drug metabolism in rat liver microsomes assessed as formation of (S)-2-(8-fluoro-6-(3-methylisoxazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-(3-methoxyquinolin-6-yl)ethanol in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414930,,,389.39,0.0,4.24,M1,Cc1cc(-c2cc(F)c3nnc([C@@H](C)c4ccc5ncc(O)cc5c4)n3c2)on1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418532,"Drug level in rat liver microsomes treated with 5-(8-Fluoro-3-(1-(3-methoxyquinolin-6-yl)ethyl)[1,2,4]-triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414931,,,419.42,0.0,3.72,M2,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(CO)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418532,"Drug level in rat liver microsomes treated with 5-(8-Fluoro-3-(1-(3-methoxyquinolin-6-yl)ethyl)[1,2,4]-triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414925,,,403.42,0.0,4.54,(S)-21e,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418535,"Drug metabolism in rat liver microsomes assessed as formation of (S)-(5-(8-fluoro-3-(1-(3-methoxyquinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)isoxazol-3-yl)methanol in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',538.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257797,Drug metabolism in Wistar rat liver microsomes assessed as recovered CCNU level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,538.0
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',3.57,%,,,,UO_0000187,,,,,0,CHEMBL3257801,Drug metabolism in Wistar rat liver microsomes assessed as total trans-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,3.57
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',6.34,%,,,,UO_0000187,,,,,0,CHEMBL3257803,Drug metabolism in Wistar rat liver microsomes assessed as total trans-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,6.34
CHEMBL3288136,,,414.82,0.0,4.12,2,COc1ccc(Cl)cc1NC(=O)N1CCN(c2ncccc2C(F)(F)F)CC1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3291845,Drug metabolism in rat liver microsomes assessed as oxidation in pyridinyl piperazine region,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3286122,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3314782,,,440.1,0.0,3.13,M4,CNc1nc2cc[nH]c(=O)c(Cc3cc(Br)c(O)c(Br)c3)c-2n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3372678,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine B for 60 mins assessed as metabolite level in presence of 1 mM NADPH at pH 7.4 and 37 degC by Quadrupole-time-of-flight mass spectrometry,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,
CHEMBL3337524,,,342.87,0.0,4.3,33,O=c1c(Cl)c(N2CCC(c3ccccc3)CC2)ccn1CC1CC1,Drug metabolism,'=',30.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,30.0
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540535,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 5-hydroxy-5-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)benzyl)thiazolidine-2,4-dione at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526469,,,413.46,0.0,2.38,M18,COc1ccc2nc(COc3ccc(CC4(O)SC(=O)NC4=O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540524,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540220,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)-2-(methylsulfonyl)propanamide at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527574,,,822.9,3.0,4.21,M6,CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(C3=O)C(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]3C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C3=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535489,Drug level in rat liver microsomes treated with gambogic acid at 50 uM preincubated for 10 mins followed by UDPGA addition measured after 2 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3398481,,,430.49,0.0,4.01,27d,CCN(CCn1ccc(-c2ccc(F)cn2)n1)C(=O)c1cc(C)ccc1-c1ncccn1,Drug metabolism,'=',97.3,%,,,,UO_0000187,,,,,0,CHEMBL3399362,Drug metabolism in rat liver microsomes at 5 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3397044,1,Scientific Literature,Bioorg Med Chem,2015,,,,,97.3
CHEMBL3338144,,,445.44,0.0,4.57,25,CCN(Cc1cc(C(F)(F)F)ccc1-c1nn(CC(=O)O)c2ccccc12)C(=O)C1CC1,Drug metabolism,'<',5.0,%,,,,UO_0000187,,,,,0,CHEMBL3377770,Drug metabolism in rat liver microsomes at 5 uM in presence of NADPH after 30 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,5.0
CHEMBL3338145,,,444.45,1.0,5.17,26,CCN(Cc1cc(C(F)(F)F)ccc1-c1cn(CC(=O)O)c2ccccc12)C(=O)C1CC1,Drug metabolism,'=',32.0,%,,,,UO_0000187,,,,,0,CHEMBL3377772,Drug metabolism in rat liver microsomes assessed as phase-2 metabolism measured by glucuronidation level at 5 uM in presence of UDPGA after 2 hrs at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,32.0
CHEMBL3613369,,,452.92,0.0,4.15,30,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2C/C=C/CF,Drug metabolism,'=',44.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,44.0
CHEMBL3622204,,,342.42,0.0,2.6,7,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3262356,,,389.46,0.0,3.22,3b,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,Drug metabolism,'=',83.0,%,,,,UO_0000187,,,,,0,CHEMBL3268719,Drug metabolism in rat liver microsomes assessed as compound remaining after 1 hr,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259804,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,83.0
CHEMBL3427724,,,367.84,0.0,4.23,11,CCCOCc1ccc(Cl)c(-c2nnc3c(C)nc4ccncc4n23)c1,Drug metabolism,'=',98.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,98.0
CHEMBL3325666,,,554.7,1.0,4.84,87,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',45.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,45.0
CHEMBL3314783,,,440.1,0.0,2.98,M6,COc1c(Br)cc(Cc2c3nc(N)nc-3cc[nH]c2=O)cc1Br,Drug metabolism,'=',23.6,%,,,,UO_0000187,,,,,0,CHEMBL3372676,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine B for 60 mins assessed as metabolite abundance in presence of 1 mM NADPH at pH 7.4 and 37 degC by reverse phase HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,23.6
CHEMBL2104148,CLOCOUMAROL,2.0,356.85,1.0,5.21,"1, clocoumarol",CCCC(c1ccc(CCCl)cc1)c1c(O)c2ccccc2oc1=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3253865,"Drug metabolism in Wistar albino rat washed liver microsomal fraction assessed as formation of 6-[1-Hydroxy-2-oxo-3-[p-(2-chloroethyl)phenyl]hexylidene]-2,4-cyclohexadien-1-one at 5 umol after 30 mins by TLC analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3244920,,,344.84,0.0,4.43,2,CCCC(C(=O)/C(O)=C1\C=CC=CC1=O)c1ccc(CCCl)cc1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3253870,"Drug metabolism Wistar albino rat liver microsomes assessed as formation of 6-[1-Hydroxy-2-oxo-3-[p-(2-chloroethyl)phenyl]hexylidene]-2,4-cyclohexadien-1-one at 5 umol after 30 mins by TLC analysis in presence of carbon monooxide",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3542372,,,638.88,2.0,3.3,"M1-1, 26-hydroxy Rh2",C/C(=C\CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C)CO,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542283,,,652.87,2.0,3.39,"M2-3, 26-carboxy Rh2",C/C(=C\CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3577937,,,455.57,0.0,4.62,4c,CCCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.17,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.17
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',498.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257797,Drug metabolism in Wistar rat liver microsomes assessed as recovered CCNU level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,498.0
CHEMBL3113988,,,561.65,1.0,2.23,11,C[C@@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@@H]2[C@H](O)C3)cc1)C(F)(F)F,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3119601,Drug metabolism in rat liver microsomes assessed as oxidation of thiophene ring,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112561,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3268081,"Metabolic stability in rat liver microsomes assessed as metabolite M4 (9-methyl-3-(2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)vinyl)-9H-pyrido[2,3-b]indole 1-oxide) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3262305,,,395.42,0.0,4.73,M2,C[N+]1([O-])c2ccccc2-c2cc(/C=C/Oc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3236342,,,506.55,1.0,2.42,64,CC(=O)Nc1ccc(S(=O)(=O)NCc2noc(-c3c4ccccc4nn3CCn3ccnc3)n2)cc1,Drug metabolism,'=',54.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,54.0
CHEMBL3236343,,,413.44,0.0,2.91,"6, CFM6104",O=C(NCc1noc(-c2nn(CCn3ccnc3)c3ccccc23)n1)c1ccccc1,Drug metabolism,'=',47.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,47.0
CHEMBL3139138,,,414.94,0.0,3.24,3,CCN1CCN(c2nc(C)nc3c2nc(-c2ccccc2Cl)n3CCOC)CC1,Drug metabolism,'=',53.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,53.0
CHEMBL3357338,,,458.99,0.0,3.43,4,CCN1CCN(c2nc(C)nc3c2nc(-c2ccccc2Cl)n3C(COC)COC)CC1,Drug metabolism,'=',58.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,58.0
CHEMBL3357340,,,400.91,0.0,2.76,7,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n([C@@H](C)CO)c2n1,Drug metabolism,'=',79.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,79.0
CHEMBL3357342,,,414.94,0.0,2.98,9,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n(CC(C)(C)O)c2n1,Drug metabolism,'=',92.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,92.0
CHEMBL3542241,,,284.32,0.0,1.7,DPH-124921,COc1ccc(-c2c(C)nn3c(N)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530618,Drug metabolism in rat liver microsomes assessed as DPH-123554 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526190,,,402.84,0.0,1.94,DB868,CO/N=C(\N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/OC)cn3)o2)nc1.Cl,Drug metabolism,'=',43.0,%,,,,UO_0000187,,,,,0,CHEMBL3536990,Prodrug conversion in rat liver microsomes assessed as depletion of compound at 10 uM after 180 mins incubation by HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525966,1,Scientific Literature,Drug Metab Dispos,2013,,,,,43.0
CHEMBL722,PROPYNAL,,54.05,0.0,-0.18,Propiolaldehyde,C#CC=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3232467,Drug level in Sprague-Dawley rat liver microsomes treated with phenobarbital by GC-MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3228041,1,Scientific Literature,J Med Chem,1979,,,,,
CHEMBL3577935,,,441.54,0.0,4.23,4a,CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.01,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.01
CHEMBL30678,,,321.43,0.0,3.12,6,CN(C)c1ccc(-c2cc3ncccc3c(NCCCN)n2)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622208,,,399.47,0.0,3.28,11,COc1ccc(-c2cc3ncsc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3542293,,,326.4,0.0,3.03,DPH-123554,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(O)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530623,Drug metabolism in rat liver microsomes assessed as DPH-124921 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3342554,,,482.56,0.0,2.49,9,CNC(=O)O[C@H]1CCc2ccc(N3CCN(C4COC4)CC3)cc2[C@@H]1NC(=O)c1ccc(F)cc1,Drug metabolism,'<',20.0,%,,,,UO_0000187,,,,,0,CHEMBL3387380,Drug metabolism in rat liver microsomes after 30 mins at 4 uM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351795,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,20.0
CHEMBL3325660,,,584.72,1.0,4.47,81,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',32.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,32.0
CHEMBL3325783,,,590.68,2.0,5.09,92,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',27.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,27.0
CHEMBL3262306,,,383.41,0.0,3.68,M3,OC(COc1ncccc1-c1cncnc1)c1cnc2[nH]c3ccccc3c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3337505,,,350.47,0.0,3.09,13,CC(C)CCn1ccc(N2CCN(c3ccccc3)CC2)c(C#N)c1=O,Drug metabolism,'=',90.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,90.0
CHEMBL3325803,,,632.16,1.0,4.26,100,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',7.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,7.0
CHEMBL3325896,,,586.1,1.0,4.67,52z,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C,Drug metabolism,'=',18.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,18.0
CHEMBL3358435,,,361.45,0.0,2.94,11,CCn1nccc1Oc1cc(CCCC(C)(C)O)cnc1NC(=O)NC,Drug metabolism,'=',10.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,10.0
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265936,"Metabolic stability in rat liver microsomes assessed as metabolite M5 (2-(2-(9-methyl-9H-pyrido[2,3-b]indol-3-yl)vinyloxy)-3-(pyrimidin-5-yl)pyridine 1-oxide) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL3257799,Drug metabolism in Wistar rat liver microsomes assessed as total trans-2-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,0.23
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',2.84,%,,,,UO_0000187,,,,,0,CHEMBL3257799,Drug metabolism in Wistar rat liver microsomes assessed as total trans-2-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,2.84
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',3.18,%,,,,UO_0000187,,,,,0,CHEMBL3257803,Drug metabolism in Wistar rat liver microsomes assessed as total trans-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,3.18
CHEMBL3113988,,,561.65,1.0,2.23,11,C[C@@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@@H]2[C@H](O)C3)cc1)C(F)(F)F,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3119600,Drug metabolism in rat liver microsomes assessed as cleavage of sufonamide,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112561,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3112926,,,251.29,0.0,2.95,56,Oc1c(CNc2ccccn2)ccc2cccnc12,Drug metabolism,'=',0.149,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.149
CHEMBL4106207,,,530.66,1.0,3.31,M8,CC(CC(=O)CC(C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CC(O)C(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535534,Drug level in Sprague-Dawley rat liver microsomes assessed as compound formation treated with ganoderic acid D at 100 uM after 1 hr by UPLC/Q-TOF analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526082,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3577939,,,469.59,0.0,4.87,4e,CC(C)CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.08,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.08
CHEMBL3337499,,,296.37,0.0,3.35,7,CC(C)CCn1ccc(OCc2ccccc2)c(C#N)c1=O,Drug metabolism,'=',90.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,90.0
CHEMBL3338149,,,445.44,0.0,4.43,30,CCN(Cc1cc(C(F)(F)F)ccc1-n1cc(CC(=O)O)c2cccnc21)C(=O)C1CC1,Drug metabolism,'=',6.0,%,,,,UO_0000187,,,,,0,CHEMBL3377772,Drug metabolism in rat liver microsomes assessed as phase-2 metabolism measured by glucuronidation level at 5 uM in presence of UDPGA after 2 hrs at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352694,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,6.0
CHEMBL3823131,,,340.43,0.0,3.88,8,CN(c1ccc2[nH]c(=O)sc2c1)c1nc(-c2ccccn2)cs1,Drug metabolism,'=',82.2,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,82.2
CHEMBL3822825,,,322.39,0.0,3.32,(+)-13,C[C@@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccccn2)n1,Drug metabolism,'=',95.3,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,95.3
CHEMBL3337506,,,351.45,0.0,2.49,14,CC(C)CCn1ccc(N2CCN(c3ccccn3)CC2)c(C#N)c1=O,Drug metabolism,'=',54.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,54.0
CHEMBL3355466,,,449.99,0.0,2.96,24,[2H][C@@]1(C)Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1cc(Cl)nc2[nH]ccc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3372396,Metabolic stability in rat liver microsomes assessed as level of cyanide adduct after 60 mins at 20 uM by cyanide trapping assay,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351372,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL3828278,,,308.21,0.0,4.54,5a,O[C@H](c1ccccn1)C1(c2ccc(Cl)c(Cl)c2)CCC1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3829499,Drug metabolism in rat liver microsomes assessed as cyclobutane ring oxidation after 1 hr by HPLC analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3826935,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3125384,,,466.36,0.0,2.96,"11, enantiomer 1",CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O,Drug metabolism,'=',7.0,%,,,,UO_0000187,,,,,0,CHEMBL3131280,Drug metabolism in rat liver microsomes assessed as compound lability,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3124816,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,7.0
CHEMBL3337520,,,363.46,0.0,3.52,29,COc1ccc(C2CCN(c3ccn(CC4CC4)c(=O)c3C#N)CC2)cc1,Drug metabolism,'=',57.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,57.0
CHEMBL3357337,,,428.97,0.0,3.63,2,CCN1CCN(c2nc(C)nc3c2nc(-c2ccccc2Cl)n3CCCOC)CC1,Drug metabolism,'=',71.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,71.0
CHEMBL2177904,,,381.41,0.0,3.69,(S)-25,NC1=N[C@](c2ccncc2)(c2cccc(-c3cncnc3)c2)c2cccc(F)c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531284,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as 2-(3-amino-4-fluoro-1-(pyridin-4-yl)-1H-isoindol-1-yl)-4-(pyrimidin-5-yl)phenol formation at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3325806,,,547.06,1.0,4.41,52i,CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',25.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,25.0
CHEMBL3337500,,,309.41,0.0,3.4,8,CC(C)CCn1ccc(N(C)Cc2ccccc2)c(C#N)c1=O,Drug metabolism,'=',100.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,100.0
CHEMBL3337519,,,363.46,0.0,3.52,28,COc1ccccc1C1CCN(c2ccn(CC3CC3)c(=O)c2C#N)CC1,Drug metabolism,'=',68.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,68.0
CHEMBL3786383,,,447.58,0.0,4.29,A,Nc1ncnc2c1c(-c1cccc(OC[C@H]3CCCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3792013,"Drug metabolism in rat liver microsomes assessed as 3-(4-amino-7-((cis)-3-(azetidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenol metabolite formation after 1 hr by capillary-HPLC/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3785066,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,
CHEMBL3325630,,,591.16,1.0,4.76,52c,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C.Cl,Drug metabolism,'=',52.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,52.0
CHEMBL3527500,,,331.59,0.0,5.0,2'-OH-TCC,O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc(Cl)cc1O,Drug metabolism,'=',2600.0,pmol/min/mg,,,,,,,,,0,CHEMBL3531134,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as glucuronidation incubated for 5 mins prior to UDPGA addition measured after 5 to 30 mins by LC-UV analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525967,1,Scientific Literature,Drug Metab Dispos,2012,,,,,2600.0
CHEMBL3337513,,,351.42,0.0,3.65,22,N#Cc1c(N2CCC(c3ccccc3F)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',42.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,42.0
CHEMBL3613366,,,426.88,0.0,3.59,27,CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2CCF,Drug metabolism,'=',14.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,14.0
CHEMBL517539,,,394.86,0.0,3.16,"1, SSR180575",CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',14.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,14.0
CHEMBL3613361,,,484.96,0.0,4.29,15,CN(C)C(=O)Cc1nn(-c2ccc(OCCCCF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',13.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,13.0
CHEMBL3622205,,,343.41,0.0,2.0,8,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622207,,,343.41,0.0,2.0,10,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622698,,,380.38,0.0,3.43,15,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3823222,,,322.39,0.0,3.32,rac-13,CC(c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccccn2)n1,Drug metabolism,'=',84.0,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,84.0
CHEMBL3325792,,,594.64,2.0,5.16,52n,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C,Drug metabolism,'=',14.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,14.0
CHEMBL3325804,,,642.16,2.0,5.66,101,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',31.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,31.0
CHEMBL375462,,,304.74,0.0,1.83,"M2, CF2246, O-desmethyl BIIB021,",Cc1cnc(Cn2cnc3c(Cl)nc(N)nc32)c(C)c1O,Drug metabolism,'=',4.5,%,,,,UO_0000187,,,,,0,CHEMBL3536546,Drug level in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity treated with [14C]BIIB021 at 10 uM after 90 mins by LC-RAM-MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,4.5
CHEMBL3824269,,,366.45,0.0,2.86,(-)-24,C[C@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccc(CCO)cn2)n1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL2057801,,,386.89,0.0,2.2,5,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n(CCO)c2n1,Drug metabolism,'=',6.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,6.0
CHEMBL2104148,CLOCOUMAROL,2.0,356.85,1.0,5.21,"1, clocoumarol",CCCC(c1ccc(CCCl)cc1)c1c(O)c2ccccc2oc1=O,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3253869,"Drug metabolism in Wistar albino rat liver soluble microsomal fraction assessed as formation of 6-[1-Hydroxy-2-oxo-3-[p-(2-chloroethyl)phenyl]hexylidene]-2,4-cyclohexadien-1-one",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3577936,,,443.51,0.0,3.08,4b,COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.01,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.01
CHEMBL3577938,,,457.54,0.0,3.47,4d,COCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,Drug metabolism,'=',0.27,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.27
CHEMBL3325659,,,570.69,1.0,3.82,80,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',17.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,17.0
CHEMBL3325782,,,572.69,1.0,4.79,91,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',36.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,36.0
CHEMBL3314783,,,440.1,0.0,2.98,M6,COc1c(Br)cc(Cc2c3nc(N)nc-3cc[nH]c2=O)cc1Br,Drug metabolism,'=',1.9,%,,,,UO_0000187,,,,,0,CHEMBL3372675,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine A for 60 mins assessed as metabolite abundance in presence of 1 mM NADPH at pH 7.4 and 37 degC by reverse phase HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,1.9
CHEMBL3542191,,,298.41,0.0,0.75,B11,C[C@@H](CO)[C@]1(C)SC(N[C@H]2C[C@H]3C[C@@H]2[C@H](O)C3)=NC1=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3539085,"Drug level in rat liver microsomes treated with (S)-2-((1S,2S,4R,6R)-6-hydroxybicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one at 20 uM preincubated for 5 mins followed by NADPH addition measured after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525943,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3357341,,,414.94,0.0,2.93,8,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n(C(C)(C)CO)c2n1,Drug metabolism,'=',93.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,93.0
CHEMBL3337507,,,364.49,0.0,3.09,15,CC(C)CCn1ccc(N2CCN(Cc3ccccc3)CC2)c(C#N)c1=O,Drug metabolism,'=',85.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,85.0
CHEMBL3542293,,,326.4,0.0,3.03,DPH-123554,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(O)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530618,Drug metabolism in rat liver microsomes assessed as DPH-123554 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3401175,,,295.34,0.0,2.49,3c,O=c1n(CC2CC2)ccc2nc(COc3ccccc3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401177,,,335.34,0.0,3.2,3e,O=c1n(-c2ccc(F)cc2)ccc2nc(COc3ccccc3)cn12,Drug metabolism,'=',27.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,27.0
CHEMBL3401188,,,353.33,0.0,3.34,3p,O=c1n(-c2ccc(F)cc2)ccc2nc(COc3ccc(F)cc3)cn12,Drug metabolism,'=',29.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,29.0
CHEMBL3325629,,,499.62,1.0,5.08,51,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C,Drug metabolism,'=',64.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,64.0
CHEMBL3337503,,,349.48,0.0,4.15,11,CC(C)CCn1ccc(N2CCCC(c3ccccc3)C2)c(C#N)c1=O,Drug metabolism,'=',98.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,98.0
CHEMBL3542241,,,284.32,0.0,1.7,DPH-124921,COc1ccc(-c2c(C)nn3c(N)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530628,Drug metabolism in rat liver microsomes assessed as BMS-572273 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3244920,,,344.84,0.0,4.43,2,CCCC(C(=O)/C(O)=C1\C=CC=CC1=O)c1ccc(CCCl)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3253855,Drug level in Wistar albino rat liver microsomes treated with clocoumarol at 5 umol after 30 mins TLC analysis in presence of NADPH generating system,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3403751,,,367.81,1.0,5.4,14b,COc1cc(C)c(-c2cnc3[nH]c(-c4c(F)cccc4Cl)cc3c2)cn1,Drug metabolism,'=',10.0,%,,,,UO_0000187,,,,,0,CHEMBL3405052,Drug metabolism in rat liver microsomes at 5 uM after 30 mins in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399948,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,10.0
CHEMBL3337518,,,401.43,0.0,4.53,27,N#Cc1c(N2CCC(c3cccc(C(F)(F)F)c3)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',39.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,39.0
CHEMBL3125936,,,354.36,0.0,2.22,"3, HFI-419",CCOC(=O)C1=C(NC(C)=O)Oc2cc(O)ccc2C1c1cccnc1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3130740,Drug metabolism in rat liver microsomes assessed as formation of glucuronide metabolites at 1 uM by LC-MS analysis in presence of NADPH and UDPGA,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3124862,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3358431,,,372.47,0.0,3.68,7,CCc1ncccc1Oc1cc(CCCC(C)(C)O)cnc1NC(=O)NC,Drug metabolism,'=',17.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,17.0
CHEMBL3358434,,,347.42,0.0,2.81,10,CCn1nccc1Oc1cc(CCCCOC)cnc1NC(=O)NC,Drug metabolism,'=',31.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,31.0
CHEMBL3092218,,,551.01,1.0,3.83,"25, trans-rac-25",C[C@H]1[C@H](N(C2CC2)S(=O)(=O)c2cccc(C(F)(F)F)c2)CN1C(=O)c1ccc(S(C)(=O)=O)cc1Cl,Drug metabolism,'=',0.11,uM,,,,UO_0000064,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,0.11
CHEMBL3325808,,,615.06,2.0,5.34,52k,Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1,Drug metabolism,'=',3.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,3.0
CHEMBL3325893,,,567.13,1.0,4.47,52ad,CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C,Drug metabolism,'=',32.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,32.0
CHEMBL3325788,,,634.76,2.0,6.16,97,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',27.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,27.0
CHEMBL3781527,,,861.86,2.0,3.8,3; 3FDT,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)C12)C3(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3783099,Drug metabolism in rat liver microsomes assessed as metabolite M1 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3779870,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL3526443,,,414.48,0.0,3.48,M2,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)c(O)c(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3125936,,,354.36,0.0,2.22,"3, HFI-419",CCOC(=O)C1=C(NC(C)=O)Oc2cc(O)ccc2C1c1cccnc1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3130739,Drug metabolism in rat liver microsomes assessed as formation of P+16 metabolites at 1 uM by LC-MS analysis in presence of NADPH and UDPGA,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3124862,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3401176,,,331.38,0.0,3.12,3d,O=c1n(Cc2ccccc2)ccc2nc(COc3ccccc3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',69.5,%,,,,UO_0000187,,,,,0,CHEMBL3257795,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 10 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,69.5
CHEMBL3314783,,,440.1,0.0,2.98,M6,COc1c(Br)cc(Cc2c3nc(N)nc-3cc[nH]c2=O)cc1Br,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3372677,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine A for 60 mins assessed as metabolite level in presence of 1 mM NADPH at pH 7.4 and 37 degC by Quadrupole-time-of-flight mass spectrometry,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,
CHEMBL3314783,,,440.1,0.0,2.98,M6,COc1c(Br)cc(Cc2c3nc(N)nc-3cc[nH]c2=O)cc1Br,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3372678,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine B for 60 mins assessed as metabolite level in presence of 1 mM NADPH at pH 7.4 and 37 degC by Quadrupole-time-of-flight mass spectrometry,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,
CHEMBL3337517,,,367.88,0.0,4.17,26,N#Cc1c(N2CCC(c3ccc(Cl)cc3)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',21.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,21.0
CHEMBL3527496,,,936.09,3.0,4.91,M1,CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(C3=O)C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H]3C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C3=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535472,Drug level in rat liver microsomes treated with gambogic acid at 50 uM preincubated for 10 mins followed by NADPH addition measured after 2 hrs in presence of GSH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3337515,,,351.42,0.0,3.65,24,N#Cc1c(N2CCC(c3ccc(F)cc3)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',36.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,36.0
CHEMBL3414912,,,379.42,0.0,3.05,11f,Cn1cc(-c2cc(F)c3nnc(Cc4ccc5nc(N)sc5c4)n3c2)cn1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414926,,,447.47,0.0,4.56,(S)-21f,COCCOc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418542,"Drug metabolism in rat liver microsomes assessed as formation of (S)-2-(6-(1-(8-fluoro-6-(3-methylisoxazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)quinolin-3-yloxy)ethanol in presence of NADPH by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3401180,,,336.33,0.0,2.6,3h,O=c1n(-c2ccc(F)cn2)ccc2nc(COc3ccccc3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3262312,,,379.42,0.0,4.63,M9,Cn1c2ccccc2c2cc(/C=C/Oc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',272.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257797,Drug metabolism in Wistar rat liver microsomes assessed as recovered CCNU level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,272.0
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',911.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257798,Drug metabolism in Wistar rat liver microsomes assessed as recovered total OH-CCNU derivatives level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,911.0
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',66.01,%,,,,UO_0000187,,,,,0,CHEMBL3257802,Drug metabolism in Wistar rat liver microsomes assessed as total cis-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,66.01
CHEMBL3403753,,,383.81,1.0,5.1,14d,COc1cc(OC)c(-c2cnc3[nH]c(-c4c(F)cccc4Cl)cc3c2)cn1,Drug metabolism,'=',10.0,%,,,,UO_0000187,,,,,0,CHEMBL3405052,Drug metabolism in rat liver microsomes at 5 uM after 30 mins in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399948,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,10.0
CHEMBL3542242,,,285.31,0.0,1.83,BMS-572273,COc1ccc(-c2c(C)nn3c(O)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530618,Drug metabolism in rat liver microsomes assessed as DPH-123554 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3112910,,,371.44,0.0,4.85,37,COc1ccc(C(Nc2ccccn2)c2ccc3ccc(C)nc3c2O)cc1,Drug metabolism,'=',0.627,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.627
CHEMBL3414915,,,424.39,0.0,3.97,12c,COc1cnc2ccc(C(F)(F)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3401192,,,369.78,0.0,3.86,3t,O=c1n(-c2ccc(F)cc2)ccc2nc(COc3ccccc3)c(Cl)n12,Drug metabolism,'=',73.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,73.0
CHEMBL3262308,,,395.42,0.0,3.87,M5,Cn1c2ccccc2c2cc(/C=C/Oc3c(-c4cncnc4)ccc[n+]3[O-])cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3425539,,,334.38,0.0,3.22,18,CCCCOc1cncc(-c2nnc3c(C)nc4ccncc4n23)c1,Drug metabolism,'=',46.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,46.0
CHEMBL3425535,,,380.84,0.0,3.14,14,Cc1nc2ccncc2n2c(-c3cc(N4CCOCC4)ccc3Cl)nnc12,Drug metabolism,'=',53.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,53.0
CHEMBL2029786,,,266.34,0.0,3.43,5,CC(C)CCn1ccc(-c2ccccc2)c(C#N)c1=O,Drug metabolism,'=',100.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,100.0
CHEMBL3337512,,,389.42,0.0,4.45,21,N#Cc1c(N2CCC(c3ccccc3)CC2)ccn(CCCC(F)(F)F)c1=O,Drug metabolism,'=',43.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,43.0
CHEMBL3337526,,,344.89,0.0,4.54,35,CC(C)Cn1ccc(N2CCC(c3ccccc3)CC2)c(Cl)c1=O,Drug metabolism,'=',31.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,31.0
CHEMBL3425537,,,296.72,0.0,2.7,16,Cc1nc2ccncc2n2c(-c3cncc(Cl)c3)nnc12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL3425536,,,379.73,0.0,4.2,15,Cc1nc2ccncc2n2c(-c3cc(OC(F)(F)F)ccc3Cl)nnc12,Drug metabolism,'=',11.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,11.0
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3268078,Metabolic stability in rat liver microsomes assessed as metabolite M1 (3-(2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)ethyl)-9H-pyrido[23-b]indole 1-oxide) formation at 1 uM after 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3115955,,,309.33,0.0,1.44,27,NCc1noc(-c2c3ccccc3nn2CCn2ccnc2)n1,Drug metabolism,'=',57.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,57.0
CHEMBL3622698,,,380.38,0.0,3.43,15,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622206,,,342.42,0.0,2.6,9,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401199,,,334.38,0.0,3.2,4e,Cc1ccc(N2CCc3nc(COc4ccccc4)cn3C2=O)nc1,Drug metabolism,'=',98.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,98.0
CHEMBL3401201,,,352.37,0.0,3.34,4g,Cc1cc(N2CCc3nc(COc4ccccc4)cn3C2=O)ncc1F,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3358432,,,368.48,0.0,4.71,8,CCc1ncccc1Oc1cc(CC2CCCCC2)cnc1NC(=O)NC,Drug metabolism,'=',95.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,95.0
CHEMBL3542281,,,638.88,2.0,3.54,M1-5,CC(C)(O)[C@H]1CC[C@@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@]23C)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542282,,,652.87,2.0,3.39,"M2-2, 27-carboxy Rh2",C/C(=C/CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542285,,,654.88,2.0,2.51,M3-9,CC1(C)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C[C@@H](O)[C@@H]4[C@@H]([C@@](C)(O)CC[C@@H]5O[C@@]5(C)CO)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3358426,,,344.42,0.0,3.16,2,CCOCCc1cnc(NC(=O)NC)c(Oc2cccnc2CC)c1,Drug metabolism,'=',76.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,76.0
CHEMBL3526543,,,400.37,0.0,2.91,M26,Cc1c(OC[C@@H](C)O)cn2ncnc(Oc3ccc4[nH]c(C(=O)O)cc4c3F)c12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534813,Drug level in rat liver microsomes assessed as compound formation treated with 2 uM [14C]brivanib alaninate after 60 mins by LC/MS method in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526776,,,258.36,0.0,3.62,M2,Cc1cc(C(C)(C)C)c(O)c(C)c1Cc1ncc[nH]1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540538,Drug level in NADPH supplemented rat liver microsomes fraction treated with 50 uM oxymetazoline assessed as compound formation after 1 hr by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525902,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3809940,,,359.43,0.0,3.52,9d,C/C1=C/C[C@H]2CNC(=O)c3cc([nH]c32)-c2cccc3nc(C)c(nc23)NC1,Drug metabolism,'=',42.0,%,,,,UO_0000187,,,,,0,CHEMBL3812478,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM incubated for 30 mins,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,,,,,42.0
CHEMBL3622209,,,344.4,0.0,2.57,12,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3824102,,,382.45,0.0,2.69,(+)-25,C[C@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccc(OCCO)cn2)n1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3236320,,,497.44,0.0,3.81,42,O=C(NCc1noc(-c2nn(CCn3ccnc3)c3ccccc23)n1)c1cccc(OC(F)(F)F)c1,Drug metabolism,'=',78.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,78.0
CHEMBL3236326,,,470.49,0.0,2.87,48,CC(=O)Nc1ccc(C(=O)NCc2noc(-c3c4ccccc4nn3CCn3ccnc3)n2)cc1,Drug metabolism,'=',45.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,45.0
CHEMBL3236341,,,449.5,0.0,2.46,63,O=S(=O)(NCc1noc(-c2c3ccccc3nn2CCn2ccnc2)n1)c1ccccc1,Drug metabolism,'=',97.0,%,,,,UO_0000187,,,,,0,CHEMBL3242048,Metabolic stability in rat liver microsomes assessed as drug turnover at 1 uM at 40 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3232919,1,Scientific Literature,J Med Chem,2014,,,,,97.0
CHEMBL3808662,,,359.43,0.0,3.52,8e,C/C1=C\C[C@H]2CNC(=O)c3cc([nH]c32)-c2cccc3nc(C)c(nc23)NC1,Drug metabolism,'=',45.0,%,,,,UO_0000187,,,,,0,CHEMBL3812478,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM incubated for 30 mins,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,,,,,45.0
CHEMBL3262304,,,383.41,0.0,3.43,M1,[O-][n+]1cc(CCOc2ncccc2-c2cncnc2)cc2c3ccccc3[nH]c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3325805,,,630.15,1.0,4.01,"103, (D) enantiomer",CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',7.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,7.0
CHEMBL3112908,,,400.44,1.0,5.06,35,Cc1ccnc(NC(c2ccc([N+](=O)[O-])cc2)c2ccc3ccc(C)nc3c2O)c1,Drug metabolism,'=',0.271,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.271
CHEMBL3542293,,,326.4,0.0,3.03,DPH-123554,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(O)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3536126,Detection of compound level in rat liver microsomes treated with 25 uM of BMS-562086 after 3 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526775,,,276.38,0.0,1.82,M1,Cc1cc(C(C)(C)CO)c(O)c(C)c1CC1=NCCN1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540538,Drug level in NADPH supplemented rat liver microsomes fraction treated with 50 uM oxymetazoline assessed as compound formation after 1 hr by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525902,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3244920,,,344.84,0.0,4.43,2,CCCC(C(=O)/C(O)=C1\C=CC=CC1=O)c1ccc(CCCl)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3253871,Drug level in Wistar albino rat liver microsomes treated with clocoumarol at 5 umol after 30 mins by TLC analysis in presence of NADP/NAD/NADH/oxygen,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3527396,,,569.0,1.0,1.76,Haloperidol-N-glucuronide,O=C(CCC[N+]1(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534020,Drug metabolism assessed as Sprague-Dawley rat liver microsomes assessed as compound formation treated with at 100 uM haloperidol by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526000,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3358425,,,328.42,0.0,3.78,1,CCc1ncccc1Oc1cc(CC(C)C)cnc1NC(=O)NC,Drug metabolism,'=',95.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,95.0
CHEMBL3416658,,,439.51,0.0,4.19,4-3,COc1cc(/C=C2\Oc3cc(OCCN4CCCCC4)ccc3C2=O)cc(OC)c1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418422,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of desmethylated metabolite at 2 uM at pH 7.4 pre-incubated in presence of NADPH regenerating system measured after 10 to 30 mins by LC-MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414445,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL2414256,,,470.41,1.0,5.07,3e,CC(C)(C)n1nnnc1C(NCCNc1ccnc2cc(Cl)ccc12)c1ccc(Cl)cc1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3100378,Drug metabolism in rat liver microsomes assessed as 2-(5-((4-chlorophenyl)(2-(7-chloroquinolin-4-ylamino)ethylamino)methyl)-1H-tetrazol-1-yl)-2-methylpropan-1-ol level at 5 uM after 1 hr by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3098028,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265937,"Metabolic stability in rat liver microsomes assessed as metabolite M6 (3-(2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)ethyl)-9H-pyrido[2,3-b]indole) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3337516,,,367.88,0.0,4.17,25,N#Cc1c(N2CCC(c3ccccc3Cl)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',34.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,34.0
CHEMBL3358429,,,316.36,0.0,2.12,5,CCc1ncccc1Oc1cc(CCO)cnc1NC(=O)NC,Drug metabolism,'=',10.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,10.0
CHEMBL3358428,,,358.44,0.0,3.55,4,CCc1ncccc1Oc1cc(CCCCOC)cnc1NC(=O)NC,Drug metabolism,'=',41.0,%,,,,UO_0000187,,,,,0,CHEMBL3377921,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM after 30 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351938,1,Scientific Literature,ACS Med Chem Lett,2014,,,,,41.0
CHEMBL3401197,,,351.38,0.0,3.94,4c,Cc1cc(N2CCc3nc(COc4ccccc4)cn3C2=O)ccc1F,Drug metabolism,'=',37.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,37.0
CHEMBL3401204,,,371.8,0.0,4.29,4k,O=C1N(c2ccc(F)cc2)CCc2nc(COc3ccccc3)c(Cl)n21,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3528593,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 2-mercapto-3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)propanoic acid at 20 uM after 2 to 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA, UDPGA/SAM and NADPH-generating system",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3112909,,,357.41,0.0,4.55,36,COc1ccc(C(Nc2ccccn2)c2ccc3cccnc3c2O)cc1,Drug metabolism,'=',0.487,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.487
CHEMBL3526911,,,320.76,0.0,2.13,[14C]BIIB021,COc1c(C)cnc(Cn2[14cH]nc3c(Cl)nc(N)nc32)c1C,Drug metabolism,'=',99.5,%,,,,UO_0000187,,,,,0,CHEMBL3536551,Drug metabolism in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity at 10 uM after 90 mins by LC-RAM-MS analysis in absence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,99.5
CHEMBL3414735,,,391.36,0.0,4.62,10a,Fc1cc(-c2ccccn2)cn2c(C(F)(F)c3ccc4ncccc4c3)nnc12,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414925,,,403.42,0.0,4.54,(S)-21e,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3425538,,,276.3,0.0,2.35,17,Cc1ccncc1-c1nnc2c(C)nc3ccncc3n12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,
CHEMBL3314782,,,440.1,0.0,3.13,M4,CNc1nc2cc[nH]c(=O)c(Cc3cc(Br)c(O)c(Br)c3)c-2n1,Drug metabolism,'=',15.6,%,,,,UO_0000187,,,,,0,CHEMBL3372676,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine B for 60 mins assessed as metabolite abundance in presence of 1 mM NADPH at pH 7.4 and 37 degC by reverse phase HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,15.6
CHEMBL3542286,,,654.88,2.0,2.51,M3-10,CC(O)(CO)[C@@H]1CC[C@@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@]23C)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542293,,,326.4,0.0,3.03,DPH-123554,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(O)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530613,Drug metabolism in rat liver microsomes at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542227,,,447.42,0.0,3.86,M1,NC1=N[C@@](c2cccc(-c3cnc[n+]([O-])c3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534873,Drug level in Sprague-Dawley rat liver microsomes treated with AZD3839 at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540526,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(5-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)benzyl)-2,4-dioxothiazolidin-3-yl)tetrahydro-2H-pyran-2-carboxylic acid at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3092220,,,598.59,1.0,4.44,27,CS(=O)(=O)c1cc(C(F)(F)F)ccc1C(=O)N1CCC2(CCN(S(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)C1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3096374,Drug metabolism in rat liver microsomes assessed as 3-(trifluoromethyl)-benzenesulfonamide level after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3091454,1,Scientific Literature,ACS Med Chem Lett,2013,,,,,
CHEMBL3622203,,,381.36,0.0,2.83,5,C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622208,,,399.47,0.0,3.28,11,COc1ccc(-c2cc3ncsc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627508,Drug metabolism in rat liver microsomes assessed as glutathione conjugates,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622697,,,380.38,0.0,3.43,14,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3526191,,,342.79,0.0,1.97,DB829,Cl.N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cn3)o2)nc1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3536864,Prodrug conversion in rat liver microsomes treated with 10 uM DB868 after 180 mins incubation by HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525966,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL482950,PEXACERFONT,3.0,340.43,0.0,3.33,"BMS-562086, pexacerfont, DPC-A69448",CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3536126,Detection of compound level in rat liver microsomes treated with 25 uM of BMS-562086 after 3 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3427722,,,367.84,0.0,4.48,9,CCCCOc1ccc(Cl)c(-c2nnc3c(C)nc4ccncc4n23)c1,Drug metabolism,'=',98.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,98.0
CHEMBL3427725,,,407.78,0.0,4.38,12,Cc1nc2ccncc2n2c(-c3cc(COCC(F)(F)F)ccc3Cl)nnc12,Drug metabolism,'=',77.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,77.0
CHEMBL3427723,,,369.81,0.0,3.33,10,COCCOc1ccc(Cl)c(-c2nnc3c(C)nc4ccncc4n23)c1,Drug metabolism,'=',18.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,18.0
CHEMBL3799908,,,393.49,0.0,3.87,6,COc1cc(C)c(CNCC(NC(=O)c2cc(C)on2)c2ccccc2)cc1C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3803912,Drug metabolism in rat liver microsomes assessed as hydroxylated metabolite formation after 60 mins by LC/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3797080,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,
CHEMBL3356991,,,375.37,0.0,3.35,10(M-2),CC1NC(=O)Nc2nc3c(-c4ncccn4)cc(-c4cncc(F)c4)cc3n21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3374111,Drug metabolism in rat liver microsomes assessed as compound formation treated with 30 uM 1-Ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo-[d]imidazol-2-yl)urea for 1 hr,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351508,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL3577940,,,503.61,2.0,5.06,4f,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](CCc2ccccc2)C1,Drug metabolism,'=',0.26,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.26
CHEMBL3577941,,,505.58,1.0,4.51,4g,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](COc2ccccc2)C1,Drug metabolism,'=',0.29,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.29
CHEMBL1091604,,,553.65,1.0,3.9,4h,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](CS(=O)(=O)c2ccccc2)C1,Drug metabolism,'=',0.16,nmol/min/mg,,,,,,,,,0,CHEMBL3579785,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3576800,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,0.16
CHEMBL3414918,,,421.41,0.0,4.62,(R)-20c,COc1cnc2ccc([C@@](C)(F)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3416658,,,439.51,0.0,4.19,4-3,COc1cc(/C=C2\Oc3cc(OCCN4CCCCC4)ccc3C2=O)cc(OC)c1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3418421,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of monohydroxylated metabolite at 2 uM at pH 7.4 pre-incubated in presence of NADPH regenerating system measured after 10 to 30 mins by LC-MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414445,1,Scientific Literature,Eur J Med Chem,2015,,,,,
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3268079,"Metabolic stability in rat liver microsomes assessed as metabolite M2 (9-methyl-3-(2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)vinyl)-9H-pyrido[2,3-b]indole 9-oxide) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3260836,,,448.56,0.0,2.9,42,Cc1csc2nc(N3CC[C@@H](C)N(C(=O)c4ccccc4-n4nccn4)CC3)nc(N)c12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3267710,Bioactivation in rat liver microsomes assessed as GSH adducts formation relative to standard,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259632,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3785110,,,367.8,0.0,2.66,21,O=c1c2cccnc2ncn1Cc1nc(CCc2ccc(Cl)cc2)no1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3789643,"Drug metabolism in rat liver microsomes assessed as 3-((3-(2-(4-Chlorophenyl)-2-hydroxyethyl)-1,2,4-oxadiazol-5-yl)-methyl)pyrido[2,3-d]pyrimidin-4(3H)-one formation",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3784976,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3786639,,,383.8,0.0,2.15,31,O=c1c2cccnc2ncn1Cc1nc(CC(O)c2ccc(Cl)cc2)no1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3789646,"Drug level in rat liver microsomes treated with 3-((3-(4-Chlorophenethyl)-1,2,4-oxadiazol-5-yl)methyl)pyrido[2,3-d]pyrimidin-4(3H)-one",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3784976,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL4106201,,,514.66,1.0,4.34,GD,CC(CC(=O)CC(C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535531,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as 3,7(S)-dihydroxy-11,15,23-trioxolanost-8-en-26-oic acid formation at 100 uM after 1 hr by by UPLC/Q-TOF analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526082,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3618058,,,328.84,1.0,5.11,33,CCc1nc2cc(Cl)ccc2n1CCCCOc1ccccc1,Drug metabolism,'=',99.7,%,,,,UO_0000187,,,,,0,CHEMBL3619165,Metabolic stability of the compound in rat liver microsomes assessed as compound turnover at 2 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3616434,1,Scientific Literature,J Med Chem,2015,,,,,99.7
CHEMBL3542242,,,285.31,0.0,1.83,BMS-572273,COc1ccc(-c2c(C)nn3c(O)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530628,Drug metabolism in rat liver microsomes assessed as BMS-572273 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542241,,,284.32,0.0,1.7,DPH-124921,COc1ccc(-c2c(C)nn3c(N)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3536126,Detection of compound level in rat liver microsomes treated with 25 uM of BMS-562086 after 3 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',2.28,%,,,,UO_0000187,,,,,0,CHEMBL3257799,Drug metabolism in Wistar rat liver microsomes assessed as total trans-2-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,2.28
CHEMBL3542242,,,285.31,0.0,1.83,BMS-572273,COc1ccc(-c2c(C)nn3c(O)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3536126,Detection of compound level in rat liver microsomes treated with 25 uM of BMS-562086 after 3 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3581779,,,326.29,0.0,0.04,1f,[N-]=[N+]=N[C@]1(CO)O[C@@H](n2ccc(NC3CC3)nc2=O)[C@@H](F)[C@@H]1O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3584376,"Drug metabolism in rat liver microsomes assessed as 1-((2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(2-hydroxycyclopropylamino)pyrimidin-2(1H)-one formation after 2 hrs by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580594,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3414923,,,402.43,0.0,3.98,(S)-21d,COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc2c1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3418300,Drug metabolism in rat liver microsomes assessed as glutathione conjugation in presence of glutathione incubated for 2 hrs by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3414463,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3526444,,,370.43,0.0,3.04,M3,CCNC(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535682,Drug level in Sprague-Dawley rat liver microsomes treated with [18F]DPA-714 after 15 to 60 mins by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3526875,,,481.4,0.0,3.13,M5,CC[C@](O)(C(=O)NNC(=O)NCc1ccc2c(-c3ccc(F)cc3)cc(=O)oc2c1)C(F)(F)F,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530306,Drug level in NADPH fortified rat liver microsomes treated with setileuton,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526019,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL165676,,,464.48,0.0,3.88,15,COc1ccc([C@H]2Cc3c(cccc3C(F)(F)F)N(CCN(C)C)C(=O)[C@H]2OC(C)=O)cc1,Drug metabolism,'=',8.0,%,,,,UO_0000187,,,,,0,CHEMBL3134873,Drug metabolism in rat liver microsomes assessed as O-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3132812,1,Scientific Literature,Medchemcomm,2013,,,,,8.0
CHEMBL3542279,,,638.88,2.0,3.54,M1-3,CC(C)(O)[C@@H]1CC[C@@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@]23C)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526244,,,372.45,0.0,3.09,M23,COc1ccc2nc(COc3ccc(CC(S)C(=O)O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3528596,"Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 to 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA, UDPGA/SAM and NADPH-generating system",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526470,,,386.47,0.0,3.52,M19,COc1ccc2nc(COc3ccc(CC(SC)C(=O)O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3529154,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 to 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM and UDPGA/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3613360,,,470.93,0.0,3.9,14,CN(C)C(=O)Cc1nn(-c2ccc(OCCCF)cc2)c(=O)c2c1c1ccc(Cl)cc1n2C,Drug metabolism,'=',3.0,%,,,,UO_0000187,,,,,0,CHEMBL3616318,Biotransformation in Sprague-Dawley rat liver microsomes at 5 uM measured at 20 mins by HPLC/ESI-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3612023,1,Scientific Literature,Eur J Med Chem,2015,,,,,3.0
CHEMBL3262310,,,379.42,0.0,4.63,M7,Cn1c2ccccc2c2cc(/C=C\Oc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3262311,,,397.44,0.0,3.69,M8,Cn1c2ccccc2c2cc(C(O)COc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3265941,"Drug level in rat liver microsomes treated with 9-Methyl-3-(2-{[3-(pyrimidin-5-yl)pyridin-2-yl]oxy}ethyl)-9H-pyrido[2,3-b]indole at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3780839,,,861.86,2.0,3.8,M5; 7-epi-3FDT,CC(=O)O[C@@]12CO[C@@H]1C[C@@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)C12)C3(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3783093,Drug level in rat liver microsomes treated with 3FDT at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3779870,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL3618092,,,412.95,1.0,5.87,68,CCc1nc2ccccc2n1CCCCSc1nnc(-c2ccc(Cl)cc2)o1,Drug metabolism,'=',99.9,%,,,,UO_0000187,,,,,0,CHEMBL3619165,Metabolic stability of the compound in rat liver microsomes assessed as compound turnover at 2 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3616434,1,Scientific Literature,J Med Chem,2015,,,,,99.9
CHEMBL3622209,,,344.4,0.0,2.57,12,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL30678,,,321.43,0.0,3.12,6,CN(C)c1ccc(-c2cc3ncccc3c(NCCCN)n2)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622205,,,343.41,0.0,2.0,8,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3823247,,,322.39,0.0,3.32,(-)-13,C[C@H](c1ccc2[nH]c(=O)sc2c1)c1ccn(-c2ccccn2)n1,Drug metabolism,'=',96.0,%,,,,UO_0000187,,,,,0,CHEMBL3825100,Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3822422,1,Scientific Literature,J Med Chem,2016,,,,,96.0
CHEMBL3828278,,,308.21,0.0,4.54,5a,O[C@H](c1ccccn1)C1(c2ccc(Cl)c(Cl)c2)CCC1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3829501,Drug metabolism in rat liver microsomes assessed as aromatic ring oxidation after 1 hr by HPLC analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3826935,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3540529,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 2-amino-3-((1-carboxy-2-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)ethyl)disulfanyl)propanoic acid at 20 uM by radio-HPLC/LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3538328,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 2-((4-((2,4-dioxothiazolidin-5-yl)methyl)phenoxy)methyl)-1-methyl-1H-benzo[d]imidazol-6-yl hydrogen sulfate at 20 uM by radio-HPLC/LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',6.31,%,,,,UO_0000187,,,,,0,CHEMBL3257801,Drug metabolism in Wistar rat liver microsomes assessed as total trans-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,6.31
CHEMBL3781527,,,861.86,2.0,3.8,3; 3FDT,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)C12)C3(C)C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3784106,Drug metabolism in rat liver microsomes assessed as metabolite M4 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3779870,1,Scientific Literature,Eur J Med Chem,2016,,,,,
CHEMBL3139186,LY2828360,2.0,426.95,0.0,3.56,1,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n(C3CCOCC3)c2n1,Drug metabolism,'=',65.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,65.0
CHEMBL3618059,,,308.42,0.0,4.77,34,CCc1nc2ccc(C)cc2n1CCCCOc1ccccc1,Drug metabolism,'=',99.9,%,,,,UO_0000187,,,,,0,CHEMBL3619165,Metabolic stability of the compound in rat liver microsomes assessed as compound turnover at 2 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3616434,1,Scientific Literature,J Med Chem,2015,,,,,99.9
CHEMBL3092559,,,295.73,0.0,3.3,6,Cc1nc2ccncc2n2c(-c3ccccc3Cl)nnc12,Drug metabolism,'=',13.0,%,,,,UO_0000187,,,,,0,CHEMBL3430116,Drug metabolism in rat liver microsomes at 1 uM incubated for 15 mins at 37 degC,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425427,1,Scientific Literature,ACS Med Chem Lett,2015,,,,,13.0
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',5.71,%,,,,UO_0000187,,,,,0,CHEMBL3257803,Drug metabolism in Wistar rat liver microsomes assessed as total trans-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,5.71
CHEMBL3542220,,,397.41,0.0,2.93,M1a,NC1=NC(c2cc[n+]([O-])cc2)(c2cccc(-c3cncnc3)c2)c2cccc(F)c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531285,Drug level in Sprague-Dawley rat liver microsomes treated with (S)-1-pyridin-4-yl-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-3-amine at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL33899,,,354.45,1.0,6.15,"4, GW-5638",CC/C(=C(\c1ccccc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1,Drug metabolism,'=',0.0,%,,,,UO_0000187,,,,,0,CHEMBL3582771,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (E)-3-(4-((Z)-2-(3-hydroxyphenyl)-1-phenylbut-1-enyl)phenyl)acrylic acid formation at 4 uM preincubated for 10 mins followed by addition of NADPH regenerating system measured after 4 hrs by LC/MS/MS analysis hrs,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580562,1,Scientific Literature,J Med Chem,2015,,,,,0.0
CHEMBL3627897,,,523.4,2.0,5.77,7,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3cccc(F)c3)c3ccc4[nH]c(C)nc4c3)c(Cl)c2)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3778026,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (R)-2,6-dichloro-N-(2-(3-fluorophenyl)-2-hydroxy-2-(2-methyl-1H-benzo[d]imidazol-5-yl)ethyl)-4-(3-methyl-1H-1,2,4-triazol-1-yl)benzamide formation after 4 hrs by LC-MS/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3774356,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,'=',0.89,nmol/mg/min,,,,,,,,,0,CHEMBL3535675,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5-(hydroxymethyl)-7-methylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,0.89
CHEMBL3526453,,,336.36,0.0,1.95,M3,CO/N=C(\N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cn3)o2)nc1,Drug metabolism,'=',9.0,%,,,,UO_0000187,,,,,0,CHEMBL3536992,Drug level in rat liver microsomes treated with 10 uM DB868 prodrug after 180 mins incubation by HPLC-UV chromatography relative to initial prodrug concentration,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525966,1,Scientific Literature,Drug Metab Dispos,2013,,,,,9.0
CHEMBL3526471,,,385.49,0.0,2.92,M20,COc1ccc2nc(COc3ccc(CC(SC)C(N)=O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3538329,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL482950,PEXACERFONT,3.0,340.43,0.0,3.33,"BMS-562086, pexacerfont, DPC-A69448",CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530613,Drug metabolism in rat liver microsomes at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542242,,,285.31,0.0,1.83,BMS-572273,COc1ccc(-c2c(C)nn3c(O)nc(C)nc23)c(C)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530623,Drug metabolism in rat liver microsomes assessed as DPH-124921 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3526190,,,402.84,0.0,1.94,DB868,CO/N=C(\N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/OC)cn3)o2)nc1.Cl,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3536995,Drug metabolism in rat liver microsomes assessed as (Z)-6-(5-(5-carbamimidoylpyridin-2-yl)furan-2-yl)-N'-hydroxynicotinimidamide formation treated at 10 uM after 180 mins incubation by HPLC-UV chromatogram relative to initial prodrug concentration,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525966,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL3310783,,,319.34,0.0,3.5,20,N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CC1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3368873,Drug metabolism in rat liver microsomes assessed as glutathione conjugates formation in presence of GSH and NADPH after 60 mins by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351490,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3628220,,,452.56,0.0,4.01,19,CS(=O)(=O)c1ccc(-c2cnn3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)cc23)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3631994,"Drug level in rat liver microsomes treated with 5-(3-(Cyclopropylsulfonyl)phenyl)-3-(4-(methylsulfinyl)-phenyl)pyrazolo[1,5-a]pyridine at 10 uM after 1 hr by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3627607,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL3527203,,,300.32,0.0,1.18,M6,COc1c(C)cnc(Cn2cnc3c(O)nc(N)nc32)c1C,Drug metabolism,'=',0.5,%,,,,UO_0000187,,,,,0,CHEMBL3536545,Drug level in Sprague-Dawley rat pooled liver microsomes assessed as radioactivity treated with [14C]BIIB021 at 10 uM after 90 mins by LC-RAM-MS analysis in absence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526132,1,Scientific Literature,Drug Metab Dispos,2012,,,,,0.5
CHEMBL472,GLYBURIDE,4.0,494.01,0.0,3.64,GLB,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3528368,Drug metabolism in insulin treated streptozotocin-induced diabetes mellitus Sprague-Dawley rat liver microsomes assessed as remaining parent compound level at 4 uM after 60 mins in presence of 10 uM sulfaphenazole,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525979,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL488025,EXISULIND,3.0,372.42,0.0,4.03,Sulindac sulfone,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3528160,Drug metabolism in rat liver microsomes at 20 nM after 60 mins by HPLC analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525907,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3538325,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)-2-(methylsulfinyl)propanamide at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526767,,,383.43,0.0,3.04,M17,COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)[nH]c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540524,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3325801,,,605.14,1.0,4.81,98,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',11.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,11.0
CHEMBL3401179,,,353.33,0.0,3.34,3g,O=c1n(-c2ccc(F)c(F)c2)ccc2nc(COc3ccccc3)cn12,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401186,,,350.35,0.0,2.91,3n,Cc1cc(-n2ccc3nc(COc4ccccc4)cn3c2=O)ncc1F,Drug metabolism,'=',49.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,49.0
CHEMBL3542278,,,638.88,2.0,3.3,"M1-2, 27-hydroxy Rh2",C/C(=C/CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C)CO,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3542287,,,654.88,2.0,2.51,M3-11,CC(O)(CO)[C@H]1CC[C@@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@]23C)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540829,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)-2-(methylthio)propanoic acid at 20 uM after 2 to 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM and UDPGA/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526242,,,355.39,0.0,1.55,M21,COc1ccc2nc(COc3ccc(CC(O)C(N)=O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540524,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system and NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3526754,,,591.6,3.0,0.49,M9,COc1ccc2nc(COc3ccc(CC(SC(=O)N[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)C(=O)O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540217,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3622204,,,342.42,0.0,2.6,7,C[C@@H](Oc1cc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622203,,,381.36,0.0,2.83,5,C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622207,,,343.41,0.0,2.0,10,C[C@@H](Oc1nc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627507,Drug metabolism in rat liver microsomes assessed as lactam hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3527395,,,552.0,1.0,2.34,Haloperidol-o-glucuronide,O=C(CCCN1CCC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534020,Drug metabolism assessed as Sprague-Dawley rat liver microsomes assessed as compound formation treated with at 100 uM haloperidol by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526000,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL472,GLYBURIDE,4.0,494.01,0.0,3.64,NCGC00023447-04,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3530395,Drug metabolism in normal Sprague-Dawley rat liver microsomes assessed as remaining parent compound level at 4 uM after 60 mins in presence of 10 uM sulfaphenazole,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525979,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3325802,,,591.11,1.0,4.16,99,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',6.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,6.0
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',63.77,%,,,,UO_0000187,,,,,0,CHEMBL3257802,Drug metabolism in Wistar rat liver microsomes assessed as total cis-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,63.77
CHEMBL2104148,CLOCOUMAROL,2.0,356.85,1.0,5.21,"1, clocoumarol",CCCC(c1ccc(CCCl)cc1)c1c(O)c2ccccc2oc1=O,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3253864,"Drug metabolism in Wistar albino rat liver microsomes assessed as formation of 6-[1-Hydroxy-2-oxo-3-[p-(2-chloroethyl)phenyl]hexylidene]-2,4-cyclohexadien-1-one at 5 umol after 30 mins by TLC analysis in presence of nitrogen",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3244920,,,344.84,0.0,4.43,2,CCCC(C(=O)/C(O)=C1\C=CC=CC1=O)c1ccc(CCCl)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3253866,Drug level in Wistar albino rat washed liver microsomal fraction treated with clocoumarol at 5 umol after 30 mins by TLC analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3243959,1,Scientific Literature,J Med Chem,1977,,,,,
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',16.1,%,,,,UO_0000187,,,,,0,CHEMBL3257793,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 2.5 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,16.1
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',91.9,%,,,,UO_0000187,,,,,0,CHEMBL3257796,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 20 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,91.9
CHEMBL3250423,,,237.72,0.0,2.25,"4, CCNU-d4",[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O,Drug metabolism,'=',19.5,%,,,,UO_0000187,,,,,0,CHEMBL3257800,Drug metabolism in Wistar rat liver microsomes assessed as total cis-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,19.5
CHEMBL3250424,,,239.74,0.0,2.25,"3, CCNU-d6",[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H],Drug metabolism,'=',3.53,%,,,,UO_0000187,,,,,0,CHEMBL3257801,Drug metabolism in Wistar rat liver microsomes assessed as total trans-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,3.53
CHEMBL3250425,,,243.76,0.0,2.25,"2, CCNU-d10",[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],Drug metabolism,'=',4.65,%,,,,UO_0000187,,,,,0,CHEMBL3257803,Drug metabolism in Wistar rat liver microsomes assessed as total trans-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,4.65
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',91.8,%,,,,UO_0000187,,,,,0,CHEMBL3257796,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 20 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,91.8
CHEMBL3400160,,,355.34,0.0,3.77,4h,O=C1N(c2ccc(F)cc2)CCc2nc(COc3cccc(F)c3)cn21,Drug metabolism,'=',29.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,29.0
CHEMBL3245361,,,306.32,0.0,3.52,"2, Dehydrowarfarin",CC(=O)/C=C(\c1ccccc1)c1c(O)c2ccccc2oc1=O,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3254245,Drug metabolism in rat liver microsomes by LC-UV analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244411,1,Scientific Literature,J Med Chem,1978,,,,,
CHEMBL3087669,,,382.51,0.0,3.92,3h,Cc1cc(N2CC[C@H](N3CCC[C@@H]3C)C2)ccc1NC(=O)c1c(C)noc1C,Drug metabolism,'<',5.0,%,,,,UO_0000187,,,,,0,CHEMBL3089248,Drug metabolism in rat liver microsomes,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3085708,1,Scientific Literature,Bioorg Med Chem Lett,2013,,,,,5.0
CHEMBL4106241,,,946.21,3.0,1.11,M6,CC(C)(O)C(CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL4106212,,,546.66,1.0,2.28,M20,CC(CC(=O)CC(C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CC(O)C(=O)C(C)(CO)[C@@H]1C[C@@H]3O)C(=O)O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535534,Drug level in Sprague-Dawley rat liver microsomes assessed as compound formation treated with ganoderic acid D at 100 uM after 1 hr by UPLC/Q-TOF analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526082,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3527103,,,435.91,0.0,3.06,[14C]-Rivoglitazone,COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3529156,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as formation of 3-(4-((6-methoxy-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)phenyl)-2-(methylthio)propanamide at 20 uM after 2 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3622203,,,381.36,0.0,2.83,5,C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622208,,,399.47,0.0,3.28,11,COc1ccc(-c2cc3ncsc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3622208,,,399.47,0.0,3.28,11,COc1ccc(-c2cc3ncsc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc1OC,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627506,Drug metabolism in rat liver microsomes assessed as pyrazole N-demethylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3799908,,,393.49,0.0,3.87,6,COc1cc(C)c(CNCC(NC(=O)c2cc(C)on2)c2ccccc2)cc1C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3803916,Drug metabolism in rat liver microsomes assessed as N-dealkylated metabolite formation after 60 mins by LC/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3797080,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,
CHEMBL2057802,,,443.94,0.0,2.56,11,COC(=O)NCCn1c(-c2ccccc2Cl)nc2c(N3CCN(C)CC3)nc(C)nc21,Drug metabolism,'=',25.0,%,,,,UO_0000187,,,,,0,CHEMBL3379651,Drug metabolism in rat liver microsomes at 2 uM after 0.5 hr by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352465,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,25.0
CHEMBL3401205,,,351.38,0.0,3.94,4l,Cc1c(COc2ccccc2)nc2n1C(=O)N(c1ccc(F)cc1)CC2,Drug metabolism,'=',46.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,46.0
CHEMBL608844,,,567.63,1.0,-1.58,1,CCN(CC)CC.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)c2ccccc2O)[C@@H](O)[C@H]1O,Drug metabolism,'=',0.0,%,,,,UO_0000187,,,,,0,CHEMBL3590807,Drug metabolism in rat liver microsomes assessed as glucuronide formation at 100 uM incubated for 60 mins in presence of UDPGA by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3588789,1,Scientific Literature,J Med Chem,2015,,,,,0.0
CHEMBL3622697,,,380.38,0.0,3.43,14,C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)O1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3627505,Drug metabolism in rat liver microsomes assessed as pyrazole hydroxylation,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3621151,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3288343,,,394.35,0.0,3.15,34,O=C(O)c1ccccc1NC(=O)N1CCN(c2ncccc2C(F)(F)F)CC1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3291846,Drug metabolism in rat liver microsomes assessed as hydrolysis into primary urea,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3286122,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL3542280,,,638.88,2.0,3.54,M1-4,CC1(C)O[C@H]1CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3531179,Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3527579,,,331.59,0.0,5.0,3'-OH-TCC,O=C(Nc1ccc(Cl)c(O)c1)Nc1ccc(Cl)c(Cl)c1,Drug metabolism,'=',8700.0,pmol/min/mg,,,,,,,,,0,CHEMBL3531134,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as glucuronidation incubated for 5 mins prior to UDPGA addition measured after 5 to 30 mins by LC-UV analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525967,1,Scientific Literature,Drug Metab Dispos,2012,,,,,8700.0
CHEMBL3401184,,,361.41,0.0,2.53,3l,CN(C)c1cccc(-n2ccc3nc(COc4ccccc4)cn3c2=O)n1,Drug metabolism,'=',90.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,90.0
CHEMBL3103191,,,447.55,0.0,2.88,7b,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN(C)C,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3810884,Drug metabolism in rat liver microsomes in presence of ABT,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3808365,1,Scientific Literature,ACS Med Chem Lett,2016,,,,,
CHEMBL3526849,,,573.58,2.0,0.66,M13,COc1ccc2nc(COc3ccc(CC4SC(=O)N([C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)C4=O)cc3)n(C)c2c1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3540217,Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526048,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL427202,,,370.38,0.0,3.52,(S)-brivanib,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1,Drug metabolism,'=',3.5,%,,,,UO_0000187,,,,,0,CHEMBL3534822,Drug level in rat liver microsomes assessed as compound formation treated with 2 uM [14C]brivanib alaninate after 60 mins by LC/MS method in presence of 1 mM NADH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,3.5
CHEMBL3325785,,,596.73,1.0,4.34,94,CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C,Drug metabolism,'=',25.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,25.0
CHEMBL3314782,,,440.1,0.0,3.13,M4,CNc1nc2cc[nH]c(=O)c(Cc3cc(Br)c(O)c(Br)c3)c-2n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3372677,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine A for 60 mins assessed as metabolite level in presence of 1 mM NADPH at pH 7.4 and 37 degC by Quadrupole-time-of-flight mass spectrometry,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,
CHEMBL3325805,,,630.15,1.0,4.01,"103, (D) enantiomer",CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',23.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,23.0
CHEMBL3527575,,,804.89,2.0,4.59,M7,CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)C4=O)C3=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535489,Drug level in rat liver microsomes treated with gambogic acid at 50 uM preincubated for 10 mins followed by UDPGA addition measured after 2 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3398482,,,405.44,0.0,2.83,27e,CCN(CCn1ccc(-c2ccc(F)cn2)n1)C(=O)c1ccccc1-n1nccn1,Drug metabolism,'=',79.9,%,,,,UO_0000187,,,,,0,CHEMBL3399362,Drug metabolism in rat liver microsomes at 5 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3397044,1,Scientific Literature,Bioorg Med Chem,2015,,,,,79.9
CHEMBL3775906,,,539.4,1.0,4.87,M538c,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@](O)(c3cccc(F)c3)c3ccc4[nH]c(C)nc4c3)c(Cl)c2)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3778025,"Drug level in Sprague-Dawley rat liver microsomes treated with (R)-2,6-Dichloro-N-(2-(3-fluorophenyl)-2-(2-methyl-1Hbenzo[d]imidazol-5-yl)ethyl)-4-(3-methyl-1H-1,2,4-triazol-1-yl)-benzamide after 4 hrs by LC-MS/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3774356,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3736121,,,483.47,0.0,3.7,41,CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc([C@@H](C)O)n4[C@H](C)C(F)(F)F)n2)C[C@H]1F,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3737832,"Drug metabolism in rat liver microsomes assessed as cis-3-Fluoro-1-{4-[2-((R)-1-hydroxyethyl)-1-((S)-2,2,2-trifluoro-1-methylethyl)-1Himidazo[4,5-c]pyridin-6-ylamino]pyrimidin-2-yl}piperidin-4-ol",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3734664,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL1076347,TRICLOCARBAN,4.0,315.59,1.0,5.29,"TCC, Triclocarban",O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3538812,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N'-glucuronide-triclocarban formation incubated for 5 mins prior to UDPGA addition measured after 5 to 30 mins by LC-UV analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525967,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3314785,,,454.12,0.0,3.44,Ceratamine B,CNc1nc2cc[nH]c(=O)c(Cc3cc(Br)c(OC)c(Br)c3)c-2n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3373233,Drug metabolism in rat liver microsomes incubated with 10 uM ceratamine B for 60 mins assessed as metabolite formation in presence of 1 mM NADPH at pH 7.4 and 37 degC by reverse phase HPLC-UV chromatography,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351870,1,Scientific Literature,J Nat Prod,2014,,,,,
CHEMBL3542228,,,447.42,0.0,3.86,M2,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2cc[n+]([O-])c(C(F)F)c2)c2cccc(F)c21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534873,Drug level in Sprague-Dawley rat liver microsomes treated with AZD3839 at 1 uM after 30 mins by LC-MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526102,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',47.9,%,,,,UO_0000187,,,,,0,CHEMBL3257794,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 5 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,47.9
CHEMBL3262356,,,389.46,0.0,3.22,3b,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,Drug metabolism,'=',5.7,%,,,,UO_0000187,,,,,0,CHEMBL3268720,"Drug metabolism in rat liver microsomes assessed as compound 5-(1H-indol-7-ylamino)-7-((1R,2S)-2-aminocyclohexylamino)pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione level after 1 hr",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259804,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,5.7
CHEMBL3828278,,,308.21,0.0,4.54,5a,O[C@H](c1ccccn1)C1(c2ccc(Cl)c(Cl)c2)CCC1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3829502,Drug metabolism in rat liver microsomes assessed as alcohol group oxidation after 1 hr by HPLC analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3826935,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3325805,,,630.15,1.0,4.01,"103, (D) enantiomer",CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C,Drug metabolism,'=',40.0,%,,,,UO_0000187,,,,,0,CHEMBL3361769,Metabolic stability in rat liver microsomes assessed as compound metabolism after 20 mins incubation in presence of 1 mM NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352233,1,Scientific Literature,J Med Chem,2014,,,,,40.0
CHEMBL3401183,,,332.36,0.0,2.77,3k,Cc1ccnc(-n2ccc3nc(COc4ccccc4)cn3c2=O)c1,Drug metabolism,,,,,,Not Determined,,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,
CHEMBL3401195,,,337.35,0.0,3.63,4a,O=C1N(c2ccc(F)cc2)CCc2nc(COc3ccccc3)cn21,Drug metabolism,'=',19.0,%,,,,UO_0000187,,,,,0,CHEMBL3404389,Drug metabolism in rat liver microsomes assessed as compound metabolized at 1 uM after 15 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3399974,1,Scientific Literature,Bioorg Med Chem Lett,2015,,,,,19.0
CHEMBL3356987,,,375.37,0.0,3.49,4(M-2),C=CNC(=O)Nc1nc2cc(-c3cncc(F)c3)cc(-c3ncccn3)c2[nH]1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3374111,Drug metabolism in rat liver microsomes assessed as compound formation treated with 30 uM 1-Ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo-[d]imidazol-2-yl)urea for 1 hr,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3351508,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL33899,,,354.45,1.0,6.15,"4, GW-5638",CC/C(=C(\c1ccccc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1,Drug metabolism,'=',1.0,%,,,,UO_0000187,,,,,0,CHEMBL3582775,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (E)-3-(4-((Z)-2-(4-hydroxyphenyl)-1-phenylbut-1-enyl)phenyl)acrylic acid formation at 4 uM preincubated for 10 mins followed by addition of NADPH regenerating system measured after 4 hrs by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580562,1,Scientific Literature,J Med Chem,2015,,,,,1.0
CHEMBL3527054,,,356.42,0.0,4.37,(S)-Sulindac,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S@+](C)[O-])cc1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3528161,Drug metabolism in rat liver microsomes at 20 nM after 60 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525907,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL555017,GAMBOGIC ACID,,628.76,2.0,7.24,"GA, M0",CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3535490,Drug metabolism in rat liver microsomes assessed as glucuronidation product formation at 50 uM preincubated for 10 mins followed by UDPGA addition for 2 hrs measured 1 hr post beta-glucuronidase treatment by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL3527000,E-7016,2.0,349.39,0.0,2.65,E7016,O=c1[nH]nc2c3c(cccc13)Oc1ccc(CN3CCC(O)CC3)cc1-2,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3534045,Drug metabolism in rat liver microsomes assessed as ER-879123 formation at 50 uM after 60 mins in presence of NADPH by LC-MS/MS method,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525952,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL33899,,,354.45,1.0,6.15,"4, GW-5638",CC/C(=C(\c1ccccc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1,Drug metabolism,'=',82.0,%,,,,UO_0000187,,,,,0,CHEMBL3583327,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as GW-7604 formation at 4 uM preincubated for 10 mins followed by addition of NADPH regenerating system measured after 4 hrs by LC/MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3580562,1,Scientific Literature,J Med Chem,2015,,,,,82.0
CHEMBL1076347,TRICLOCARBAN,4.0,315.59,1.0,5.29,"TCC, Triclocarban",O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3534079,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N-glucuronide-triclocarban formation incubated for 5 mins prior to UDPGA addition measured after 5 to 30 mins by LC-UV analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525967,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL482950,PEXACERFONT,3.0,340.43,0.0,3.33,"BMS-562086, pexacerfont, DPC-A69448",CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530628,Drug metabolism in rat liver microsomes assessed as BMS-572273 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3627897,,,523.4,2.0,5.77,7,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3cccc(F)c3)c3ccc4[nH]c(C)nc4c3)c(Cl)c2)n1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3778024,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as (R)-2,6-dichloro-N-(2-(3-fluorophenyl)-2-(2-methyl-1H-benzo[d]imidazol-5-yl)ethyl)-4-(3-(hydroxymethyl)-1H-1,2,4-triazol-1-yl)benzamide formation after 4 hrs by LC-MS/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3774356,1,Scientific Literature,J Med Chem,2016,,,,,
CHEMBL3527054,,,356.42,0.0,4.37,(S)-Sulindac,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S@+](C)[O-])cc1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3528161,Drug metabolism in rat liver microsomes at 20 nM after 60 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525907,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',72.5,%,,,,UO_0000187,,,,,0,CHEMBL3257795,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 10 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,72.5
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',62.61,%,,,,UO_0000187,,,,,0,CHEMBL3257802,Drug metabolism in Wistar rat liver microsomes assessed as total cis-4-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,62.61
CHEMBL3526472,,,443.46,0.0,3.42,[14C]-Brivanib alaninate,Cc1cc2c(F)c(Oc3n[14cH]nn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3534810,"Drug metabolism in rat liver microsomes assessed as 1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-one formation at 2 uM after 60 mins by LC/MS method in presence of 1 mM NADPH",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3809691,,,359.43,0.0,3.52,9c,Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21,Drug metabolism,'=',39.0,%,,,,UO_0000187,,,,,0,CHEMBL3812478,Drug metabolism in rat liver microsomes assessed as compound turnover at 1 uM incubated for 30 mins,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,,,,,39.0
CHEMBL3337527,JNJ-40411813,2.0,344.89,0.0,4.69,36,CCCCn1ccc(N2CCC(c3ccccc3)CC2)c(Cl)c1=O,Drug metabolism,'=',53.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,53.0
CHEMBL762,OXYMETAZOLINE,4.0,260.38,0.0,2.85,Oxymetazoline,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535100,"Drug metabolism in NADPH supplemented rat liver microsomes fraction assessed as 3-((1H-imidazol-2-yl)methyl)-6-(1-hydroxy-2-methylpropan-2-yl)-2,4-dimethylphenol formation at 50 uM after 1 hr by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525902,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL591429,PAC-1,1.0,392.5,0.0,2.39,"1, PAC-1",C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3427873,"Drug metabolism in rat liver microsomes assessed as formation of N-dealkylated, dihydroxylated and multiple monooxygenated products at 10 uM after 3 hrs by LC/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3425441,1,Scientific Literature,J Med Chem,2015,,,,,
CHEMBL1230001,,,392.38,0.0,4.82,33,O=C(O)c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1,Drug metabolism,,,,,,metabolite_notdetected,,,,,,0,CHEMBL3291845,Drug metabolism in rat liver microsomes assessed as oxidation in pyridinyl piperazine region,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3286122,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535678,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-7-(hydroxymethyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535679,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N,N-diethyl-2-(2-(4-hydroxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,
CHEMBL762,OXYMETAZOLINE,4.0,260.38,0.0,2.85,Oxymetazoline,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535098,"Drug metabolism in NADPH supplemented rat liver microsomes fraction assessed as 3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1-hydroxy-2-methylpropan-2-yl)-2,4-dimethylphenol formation at 50 uM after 1 hr by LC-MS/MS method",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525902,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL1200596,CHLOROXINE,4.0,214.05,0.0,3.25,"60, chloroxine",Oc1c(Cl)cc(Cl)c2cccnc12,Drug metabolism,'=',0.1,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.1
CHEMBL497,CLIOQUINOL,4.0,305.5,0.0,3.2,"58, Clioquinol",Oc1c(I)cc(Cl)c2cccnc12,Drug metabolism,'=',0.071,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.071
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"Table III, R1C1",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',26.8,%,,,,UO_0000187,,,,,0,CHEMBL3257793,Drug metabolism in Wistar rat liver microsomes at 50 ug/ml after 2.5 mins,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,26.8
CHEMBL3337510,,,333.43,0.0,3.51,19,N#Cc1c(N2CCC(c3ccccc3)CC2)ccn(CC2CC2)c1=O,Drug metabolism,'=',44.0,%,,,,UO_0000187,,,,,0,CHEMBL3378788,Metabolic stability in rat liver microsomes assessed as compound metabolized at 5 uM after 15 mins by MS/MS analysis in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3352578,1,Scientific Literature,J Med Chem,2014,,,,,44.0
CHEMBL3113979,,,533.64,1.0,3.12,"1, AMG-1694",C[C@H]1COCCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc([C@@](C)(O)C(F)(F)F)cc1,Drug metabolism,,,,,,Active,,,,,,0,CHEMBL3119603,Drug metabolism in rat liver microsomes assessed as oxidation of bicyclic morpholine ring,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112561,1,Scientific Literature,J Med Chem,2014,,,,,
CHEMBL555017,GAMBOGIC ACID,,628.76,2.0,7.24,"GA, M0",CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3535488,Drug metabolism in rat liver microsomes assessed as glucuronidation product formation at 50 uM preincubated for 10 mins followed by UDPGA addition measured after 2 hrs by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL54,HALOPERIDOL,4.0,375.87,0.0,4.43,haloperidol,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3539916,Drug metabolism assessed as Sprague-Dawley rat liver microsomes assessed as velocity of O-glucuronidation at 100 uM by LC-MS/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526000,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL555017,GAMBOGIC ACID,,628.76,2.0,7.24,"GA, M0",CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3535832,"Drug metabolism in rat liver microsomes assessed as 9,10-epoxyl-gambogic acid formation at 50 uM preincubated for 10 mins by LC-MS/MS analysis in absence of NADPH",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL1083358,,,431.48,0.0,3.09,2,C[C@@H]1CCN(c2ncc3cc(F)ccc3n2)CCN1C(=O)c1ccccc1-n1nccn1,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3267710,Bioactivation in rat liver microsomes assessed as GSH adducts formation relative to standard,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259632,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL1614712,,,439.56,0.0,4.92,NVP-AEW541,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,Drug metabolism,'=',11.4,%,,,,UO_0000187,,,,,0,CHEMBL3792013,"Drug metabolism in rat liver microsomes assessed as 3-(4-amino-7-((cis)-3-(azetidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenol metabolite formation after 1 hr by capillary-HPLC/MS analysis",A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3785066,1,Scientific Literature,Bioorg Med Chem Lett,2016,,,,,11.4
CHEMBL3262298,,,381.44,0.0,4.2,20d,Cn1c2ccccc2c2cc(CCOc3ncccc3-c3cncnc3)cnc21,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3268080,"Metabolic stability in rat liver microsomes assessed as metabolite M3 (1-(9H-pyrido[2,3-b]indol-3-yl)-2-(3-(pyrimidin-5-yl)pyridin-2-yloxy)ethanol) formation at 1 uM after 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3259542,1,Scientific Literature,Bioorg Med Chem Lett,2014,,,,,
CHEMBL1783834,GINSENOSIDE RH2,,622.88,2.0,4.32,Rh2,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3540851,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as epoxide metabolites at 10 uM for 60 mins by GEE/conjugate assay,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL1688558,,,327.39,0.0,4.54,57,Oc1c(C(Nc2ccccn2)c2ccccc2)ccc2cccnc12,Drug metabolism,'=',0.637,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.637
CHEMBL589706,,,386.41,0.0,4.75,34,Cc1ccnc(NC(c2ccc([N+](=O)[O-])cc2)c2ccc3cccnc3c2O)c1,Drug metabolism,'=',0.13,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.13
CHEMBL472,GLYBURIDE,4.0,494.01,0.0,3.64,GLB,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3530396,Drug metabolism in streptozotocin-induced diabetes mellitus Sprague-Dawley rat liver microsomes assessed as remaining parent compound level at 4 uM after 60 mins in presence of 10 uM sulfaphenazole,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525979,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"Table III, R1C1",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',1230.0,ug,,,,UO_0000023,,,,,0,CHEMBL3257798,Drug metabolism in Wistar rat liver microsomes assessed as recovered total OH-CCNU derivatives level at 2.8 mg after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,1230.0
CHEMBL1783834,GINSENOSIDE RH2,,622.88,2.0,4.32,Rh2,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,Drug metabolism,,,,,,metabolite_not_detected,,,,,,0,CHEMBL3536235,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as epoxide metabolites at 10 uM for 60 mins by GSH/conjugate assay,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525925,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL555017,GAMBOGIC ACID,,628.76,2.0,7.24,"GA, M0",CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3532169,Drug metabolism in rat liver microsomes assessed as formation of 10-glutathionyl gambogic acid at 50 uM preincubated for 10 mins followed by NADPH addition measured after 2 hrs in presence of GSH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526153,1,Scientific Literature,Drug Metab Dispos,2011,,,,,
CHEMBL482950,PEXACERFONT,3.0,340.43,0.0,3.33,13-15,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530618,Drug metabolism in rat liver microsomes assessed as DPH-123554 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL514,LOMUSTINE,4.0,233.7,0.0,2.25,"1, CCNU, CCNU-d0",O=NN(CCCl)C(=O)NC1CCCCC1,Drug metabolism,'=',19.95,%,,,,UO_0000187,,,,,0,CHEMBL3257800,Drug metabolism in Wistar rat liver microsomes assessed as total cis-3-OH CCNU level at 50 ug/ml after 10 mins by HPLC analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3244370,1,Scientific Literature,J Med Chem,1978,,,,,19.95
CHEMBL512306,[18F]D,2.0,398.48,0.0,3.77,DPA-714,CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12,Drug metabolism,'=',0.82,nmol/mg/min,,,,,,,,,0,CHEMBL3535677,"Drug metabolism in Sprague-Dawley rat liver microsomes assessed as N-ethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide level after 15 to 60 mins by LC-MS/MS analysis",A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3525897,1,Scientific Literature,Drug Metab Dispos,2013,,,,,0.82
CHEMBL224325,CHLORQUINALDOL,4.0,228.08,0.0,3.56,"61, 2-methyl-chloroxine",Cc1ccc2c(Cl)cc(Cl)c(O)c2n1,Drug metabolism,'=',0.142,uM/min.mg,,,,,,,,,0,CHEMBL3117193,Drug metabolism in Sprague-Dawley rat liver microsomes assessed as metabolic rate at 1 uM by reversed phase LC/MS analysis,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3112564,1,Scientific Literature,J Med Chem,2014,,,,,0.142
CHEMBL482950,PEXACERFONT,3.0,340.43,0.0,3.33,13-15,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,Drug metabolism,,,,,,metabolite_detected,,,,,,0,CHEMBL3530623,Drug metabolism in rat liver microsomes assessed as DPH-124921 metabolite level at 100 uM after 1 hr in presence of NADPH,A,BAO_0000019,assay format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3526146,1,Scientific Literature,Drug Metab Dispos,2012,,,,,
CHEMBL3753475,,,437.63,0.0,4.1,3d,O=C1c2ccc(OC3CCN(C4CCC4)CC3)cc2CCN1C1CCN(C2CCC2)CC1,Drug metabolism,'=',6.0,%,,,,UO_0000187,,,,,0,CHEMBL3755250,Metabolic stability in rat liver microsomes assessed as compound metabolized after 30 mins by LC-MS/MS analysis,A,BAO_0000221,tissue-based format,Rattus norvegicus,CHEMBL3559723,Liver,,,,,,CHEMBL2367428,Liver microsome,Rattus norvegicus,TISSUE,CHEMBL3751729,1,Scientific Literature,Eur J Med Chem,2016,,,,,6.0
